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Abstract 
Background: Osteoarthritis is one of the most common chronic pain disorders, pain is 
the dominant symptom, and exercise is one of the key elements in the conservative 
management. The nature of pain in osteoarthritis patients has earlier been considered 
relatively stable. However, this view of pain is challenged in the literature.  
Objective: To evaluate pain fluctuations over time among middle-aged patients with 
mild to moderate knee osteoarthritis undergoing a 14-week exercise intervention. 
Material and Methods: This study was part of a randomized controlled trial (Oiestad 
et al., 2013) investigating the efficacy of strength and aerobic exercise in middle-aged 
patients with knee osteoarthritis. Eleven knee osteoarthritis patients were followed in 
this single subject design study. During a 16 week period (1 week baseline + 14 week 
intervention + 1 week post intervention) patients were regularly (assessments daily 
during the baseline phase and the post intervention phase, weekly during the 
intervention phase) assessed with the pain subscale of the Knee Osteoarthritis Outcome 
score (KOOS) and the Numeric Rating Scale (NRS) for pain. 
Results: The mean fluctuation (difference between the highest score and the lowest) 
during the intervention phase was 28 points measured with the KOOS pain and 7 points 
measured with the NRS for pain. Comparing with the post intervention phase, pain 
fluctuation measured with the KOOS pain was higher during the intervention phase for 
all subjects except one. Measured with the NRS for pain, all subjects had higher pain 
fluctuation during the intervention phase compared to the post intervention phase. 
Comparing the post intervention phase with the baseline phase, all but two subjects had 
higher pain fluctuations at the baseline phase compared to the post intervention phase 
measured with the KOOS pain. Measured with the NRS for pain, all but one subject had 
higher pain fluctuations at the baseline phase compared to the post intervention phase. 
Conclusion: This study showed that overall, according to a cutoff of ten points for the 
KOOS pain and two points for the NRS for pain patients with knee osteoarthritis 
reported clinically meaningful (MCID) pain fluctuations during a 14-week intervention 
period. Pain fluctuations varied substantially among the eleven subjects. In general, pain 
fluctuated less at the post intervention phase compared to the baseline phase and the 
intervention phase. The results from this study add to the literature documenting pain 
fluctuations in patients with knee osteoarthritis. 
4 
 
Table of contents 
Abstract .......................................................................................... 3 
Table of contents ........................................................................... 4 
Acknowledgements ....................................................................... 6 
1. Introduction ............................................................................ 7 
2. Objective ............................................................................... 10 
2.1 Overall purpose ............................................................................................................ 10 
2.2 Main research question ............................................................................................... 10 
2.3 Research questions ....................................................................................................... 10 
2.4 Hypotheses .................................................................................................................... 10 
3. Theoretical background ....................................................... 11 
3.1 Definition and classification ........................................................................................ 11 
3.2 Diagnosis ....................................................................................................................... 11 
3.3 Epidemiology ................................................................................................................ 13 
3.4 Pathophysiology ........................................................................................................... 14 
3.5 Risk factors ................................................................................................................... 16 
3.5.1 Non-modifiable risk factors ..................................................................................... 16 
3.5.2 Modifiable risk factors ............................................................................................. 16 
3.6 Pain and symptoms ...................................................................................................... 17 
3.6.1 Pain .......................................................................................................................... 18 
3.6.2 How pain manifests in patients with osteoarthritis .................................................. 19 
3.6.3 Biopsychosocial model of osteoarthritis pain .......................................................... 21 
3.6.4 Potential pain mechanisms in osteoarthritis............................................................. 22 
3.6.5 Pain assessment ....................................................................................................... 26 
3.7 Treatment ..................................................................................................................... 27 
3.7.1 Non-pharmacological treatment .............................................................................. 28 
3.7.2 Pharmacological treatment ...................................................................................... 32 
3.7.3 Surgical treatment .................................................................................................... 32 
3.7.4 Summary .................................................................................................................. 32 
4. Methods ................................................................................ 34 
4.1 Design ............................................................................................................................ 34 
4.2 Subjects ......................................................................................................................... 35 
5 
 
4.3 Data collection .............................................................................................................. 37 
4.4 Assessments .................................................................................................................. 38 
4.5 Intervention .................................................................................................................. 40 
4.6 Statistical methods ....................................................................................................... 41 
4.7 Ethical perspectives ..................................................................................................... 41 
5. Results .................................................................................. 42 
5.1 Subject characteristics at baseline .............................................................................. 42 
5.2 Assessments .................................................................................................................. 43 
5.3 Summary of results ...................................................................................................... 43 
5.4 Were baseline and post intervention KOOS pain scores in the ongoing 
randomized controlled trial (Oiestad et al., 2013) similar to KOOS pain 
scores in this study? ..................................................................................................... 47 
6. Discussion ............................................................................ 49 
6.1 Discussion of results ..................................................................................................... 50 
6.1.1 How did pain fluctuate during the 14-weeks intervention? ..................................... 50 
6.1.2 Were pain fluctuations at baseline, during the 14-week intervention and at 
post intervention different from each other? ............................................................ 53 
6.1.3 Were baseline and post intervention KOOS pain scores different from the 
KOOS pain scores these same individuals reported in the randomized 
controlled trial (Oiestad et al., 2013)? ..................................................................... 54 
6.2 Discussion of methods .................................................................................................. 55 
6.2.1 Subjects .................................................................................................................... 55 
6.2.2 Study design ............................................................................................................ 56 
6.2.3 Outcome measures ................................................................................................... 59 
6.2.4 How the data was presented .................................................................................... 60 
6.3 Clinical implications .................................................................................................... 61 
6.4 Future research ............................................................................................................ 61 
7. Conclusion ............................................................................ 62 
Reference List .............................................................................. 63 
Tables ........................................................................................... 83 
Figures ......................................................................................... 84 
Acronyms and definitions ........................................................... 85 
Appendix ...................................................................................... 86 
6 
 
Acknowledgements 
First and foremost I would like to thank my fantastic supervisor May Arna Risberg for 
guiding me through this master’s thesis. I am very thankful for all the time you spent 
helping me. Your enthusiasm and knowledge for science is admiring. 
Margreth Grotle, thank you for great feedbacks and sharing of your great knowledge in 
the area of pain science.  
Britt Elin Øiestad and Kristin Bølstad, thank you for helping me with the data 
collection. You were always so positive and helpful. 
Thanks to my girlfriend for proofreading and supporting me through the process. 
I would also like to thank all the patients who participated in this study. Thank you for 
answering all the questionnaires. 
 
 
Joakim Mælashaug Ordahl 
May 2015, Oslo 
  
7 
 
1. Introduction 
Osteoarthritis is one of the most prevalent chronic pain disorders (Lawrence et al., 
1998), and the knee joint is commonly affected (Dieppe & Lohmander, 2005). The most 
dominant symptom associated with osteoarthritis is pain (Bijlsma et al., 2011). Pain in 
osteoarthritis patients has earlier been considered relatively stable, and changes of the 
pain experience has been associated with activity and rest (Allen et al., 2009). However, 
this view of pain in osteoarthritis is challenged in the literature. 
Osteoarthritis has been diagnosed primarily with plain radiography (X-rays) and clinical 
examination for many decades (Cibere, 2006), however radiographic findings are an 
imprecise marker to what extend a knee is painful (Bedson & Croft, 2008). Hence, there 
is likely that several mechanisms are influencing the pain experience in people with 
knee osteoarthritis (Maly, Costigan, & Olney, 2008). Why there is a poor correlation 
between disease severity and the level of pain and disability reported lack knowledge 
(Hunter, McDougall, & Keefe, 2009). 
Historically, cartilage damage was believed to be the main reason for the pain 
experience in people with osteoarthritis. Today there is a perception that several other 
factors are influencing the pain experience. Other type of joint damage such as effusion, 
synovial thickening and bone attrition are among factors related (Maly et al., 2008). 
Imaging studies have shown the presence of inflammation, synovitis and bone marrow 
lesions which may mediate pain (Sofat, Ejindu, & Kiely, 2011). Among other factors 
with significant impact on pain experience in this patient population are psychological 
factors (Maly et al., 2008). Psychological factors may modulate pain signals, hence 
influencing the pain perception. Moreover, peripheral sensitization and especially 
central sensitization have been proposed as two of the underlying pain mechanisms in 
osteoarthritis (Lluch, Nijs, Torres-Cueco, & Lopez, 2013).  
Exercise is a usual treatment to improve function and reduce pain for patients with 
osteoarthritis (Nelson, Allen, Golightly, Goode, & Jordan, 2013). Different kinds such 
as aerobic, strengthening, endurance and flexibility exercises are common, both land-
based and water-based. According to the Osteoarthritis Research Society International 
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there is good evidence for the use of the exercises mentioned for people with 
osteoarthritis of the knee (McAlindon et al., 2014).  
Despite the big amount of research done in the area of osteoarthritis there are still 
lacking knowledge why osteoarthritis are painful (Sofat et al., 2011) and why exercise 
work as treatment (Sofat et al., 2011; Beckwee, Vaes, Cnudde, Swinnen, & Bautmans, 
2013). Pain is the main reason patients with osteoarthritis seek medical help, and more 
knowledge to gain a deeper understanding of pain pathways could improve management 
of the disease (Sofat et al., 2011). 
Traditionally, pain has been assessed in clinical trials by asking patients about their 
current pain at baseline and again after intervention (Williams et al., 2004). This may 
however lead to wrong conclusions, given that pain can fluctuate widely from one week 
to the next. Assessing patients pain level over a period of time could potentially be more 
representative than one assessment at baseline and one after intervention. To our 
knowledge no study has previously investigated daily and weekly pain fluctuations in a 
Norwegian population with osteoarthritis. Earlier studies investigating pain fluctuations 
have been looking at pain fluctuations in a population not receiving an exercise 
intervention. Literature  documenting pain fluctuation in patients with osteoarthritis is 
growing, however more research is needed (Allen et al., 2009). 
The purpose of this study was therefore to evaluate pain fluctuations among knee 
osteoarthritis patients undergoing an exercise intervention. This master’s thesis was part 
of a randomized controlled trial (Oiestad et al., 2013), an ongoing investigation of the 
efficacy of strength and aerobic exercise in middle-aged patients with knee 
osteoarthritis. There are two intervention groups and one control group included in the 
ongoing study. One group has tailored strength exercises, a second group perform 
cycling (aerobic exercises), and a third control group do as they usually do (but are 
asked to not start physiotherapy treatment or exercises the first four months of the study 
period).  
The recruitment of subjects to the randomized controlled trial (Oiestad et al., 2013) 
started march 2013 and is still ongoing today. A total of 207 subjects are planned to be 
included. For this master’s thesis; 22 consecutively included patients in the randomized 
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controlled trial from August 2014 were tested for eligibility for this master’s thesis 
single subject design project. 
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2. Objective 
2.1 Overall purpose 
The purpose of this study was to evaluate pain fluctuations over time among middle-
aged patients with mild to moderate knee osteoarthritis undergoing a 14-week exercise 
intervention. 
2.2 Main research question 
How does pain fluctuate in middle-aged patients with mild to moderate knee 
osteoarthritis undergoing a 14-week exercise intervention? 
2.3 Research questions 
 Are pain fluctuations at baseline, during the 14-weeks intervention and at post 
intervention different from each other? 
 Are baseline and post intervention KOOS pain scores different from the KOOS 
pain scores these same individuals reported in the ongoing randomized 
controlled trial (Oiestad et al., 2013)?  
2.4 Hypotheses 
 Pain fluctuations is expected to be 10 points or more for the KOOS pain and 2 
points or more for the NRS for pain during the 14-week intervention 
 Pain fluctuations are decreased post intervention compared to baseline 
fluctuations and fluctuations during the 14-week intervention 
 Baseline and post intervention KOOS pain scores reported for the included 
subjects in this study are different from the KOOS pain scores they reported in 
the randomized controlled trial (Oiestad et al., 2013)  
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3. Theoretical background 
3.1 Definition and classification 
The term osteoarthritis describes pathological changes in a synovial joint (Dieppe & 
Lohmander, 2005). Joint failure results from an imbalance between mechanical stresses 
and catabolic processes acting on the joint, and the ability of the joint tissue to 
withstand and repair the damage (Nuki, 1999). When the dynamic equilibrium between 
the breakdown and repair of joint tissue is overwhelmed, it is when osteoarthritis 
occurs. Rather than being viewed as a single disease or process, osteoarthritis can be 
viewed as the clinical and pathological outcome of a range of disorders characterized by 
structural and symptomatic failure of one or more synovial joints (Nuki, 1999). 
Usually osteoarthritis is classified as either primary (idiopathic) or secondary (Nuki, 
1999). When there is no obvious single predisposing cause osteoarthritis is classified as 
primary, while when it follows some clearly defined predisposing pathologies it is 
classified as secondary. Osteoarthritis classified as primary is most common (Flugsrud 
et al., 2010), and 70-80% of Norwegians who receive a total hip or knee replacement 
are diagnosed with primary osteoarthritis (Nasjonalt kompetansesenter for leddproteser, 
2009). Most common causes for secondary are injury, infection, tumor, avascular 
necrosis, and the childhood hip disorders Legg-Calvé-Perthes syndrome, dysplasia and 
epifysiolysis (Flugsrud et al., 2010). 
3.2 Diagnosis 
The diagnosis of osteoarthritis should in clinical practice be made on the basis of your 
history and physical examination (Hunter et al., 2009). The role of radiography is to 
confirm the clinical findings and rule out other conditions. American College of 
Rheumatology have developed clinical criteria for the diagnosis and classification for 
symptomatic osteoarthritis of the knee (Altman et al., 1986). 
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Table 1: The American College of Rheumatology clinical classification criteria for symptomatic 
osteoarthritis of the knee (Altman et al., 1986). 
One must have articular knee pain for most days of the prior month, in addition to at least 3 of 
the following: 
1. Crepitus on active joint motion 
2. Morning stiffness <30 minutes duration 
3. Age >50 years 
4. Bony enlargement on the knee on examination 
5. Bony tenderness of the knee on examination 
6. No palpable warmth  
This way of classifying knee osteoarthritis gave a sensitivity of 95% and specificity of 
69% (Altman et al., 1986). In The American College of Rheumatology original 
publication several different ways of classifying osteoarthritis were proposed, giving 
different sensitivity and specificity. They also proposed classification criteria based on 
clinical examination, laboratory tests or radiographs either in combination or alone 
(Altman et al., 1986). It was believed that no single classification criteria could satisfy 
all circumstances to which the criteria for osteoarthritis of the knee would be applied, 
hence separate sets of classification criteria were developed for use in different 
circumstances.  
The American College of Rheumatology criteria for knee osteoarthritis have been 
revised several times after first being proposed in 1986 (Wu et al., 2005). Especially the 
age criteria are often used differently since osteoarthritis could occur earlier than the age 
of 50 years. In a study by Wu et al. (2005) revising these criteria, the inclusion criteria 
for age were 40 years or older. 
Kellgren and Lawrence were the first to carry out large-scale epidemiological studies of 
osteoarthritis in the 1950s. They diagnosed osteoarthritis based on x-rays (KELLGREN 
& LAWRENCE, 1957), diagnostic criteria that are still widely used (Felson, Niu, 
Guermazi, Sack, & Aliabadi, 2011).  
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Table 2:  Kellgren and Lawrence classification system (KELLGREN & LAWRENCE, 1957). 
Grade Description 
0 No changes 
1 Doubtful narrowing of joint space and possible osteophytic lipping 
2 Definite osteophytes and possible narrowing of joint space 
3 Moderate multiple osteophytes, definite narrowing of joint space, and some 
sclerosis, and possible deformity of bone ends 
4 Large osteophytes, marked narrowing of joint space, severe sclerosis and 
definite deformity of bone ends 
Unfortunately, neither Kellgren and Lawrence or users of their scale were consistent in 
how they described each of the grades in the classification (Felson et al., 2011). 
Especially grade 2, which usually define whether radiologic osteoarthritis is present, 
have been used inconsistently. 
3.3 Epidemiology 
Osteoarthritis is a very common disease (van Saase, van Romunde, Cats, 
Vandenbroucke, & Valkenburg, 1989), and one of the most common chronic 
musculoskeletal diseases (Pereira et al., 2011). It is the most common form of arthritis 
(Vos et al., 2012), the economic burden of osteoarthritis is enormous (Gupta, Hawker, 
Laporte, Croxford, & Coyte, 2005), and the number of people with osteoarthritis is 
increasing. Prevalence, incidence, and risk of developing the disease depend on how 
data are collected and how osteoarthritis is diagnosed. In a Norwegian study called 
“Ullernsaker-undersøkelsen” where a sample of the general population between 24-76 
years of age were included, every eighth participant reported they had the diagnosis 
diagnosed by a physician (Grotle, Hagen, Natvig, Dahl, & Kvien, 2008). A Dutch study 
found the prevalence of radiologic hip osteoarthritis to be 10-20% in the age group 70-
80 years (van Saase et al., 1989). Moreover, they found the prevalence of radiologic 
knee osteoarthritis to be 20-40% and hand osteoarthritis to be 60-80%. The American 
population has a 45% lifetime risk of developing symptomatic knee osteoarthritis 
according to a cohort study (Murphy et al., 2008). In another study also investigating 
the American population, the estimated lifetime risk for developing knee osteoarthritis 
was 14% (Losina et al., 2013). Estimated median age which knee osteoarthritis was 
diagnosed was 55 years. The authors (Losina et al., 2013) explain the difference in 
numbers with different ways of collecting data. Furthermore, projected lifetime risk was 
estimated from different ages, from 25 years in the study by Losina et al. (2013) and 
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from 45 years in the study by Murphy et al. (2008). In addition, the population was 
different in the two studies.  
The most common joints affected by osteoarthritis are hands, knees, hips, and spine 
(Dieppe & Lohmander, 2005). A single joint could be affected, however commonly 
several joints are involved. In 2013 4937 persons had a total knee replacement in 
Norway, and 4010 of those were due to osteoarthritis (Nasjonalt kompetansesenter for 
leddproteser, 2014). While osteoarthritis is very common in the knee, it is even more 
prevalent in the hands (Hunter et al., 2009). Especially the distal interphalangeal joints 
(DIP), the proximal interphalangeal joints (PIP), and the carpometacarpal joints (CMC).  
3.4 Pathophysiology 
Osteoarthritis are as mentioned a disease that affects synovial joints, and all joints are 
possibly affected (Dieppe & Lohmander, 2005). Characterizations of the disease are 
progressive cartilage loss, subchondral bone remodeling, osteophyte formation and 
synovial inflammation (see figure 1) (Hunter, 2011). When one component of the joint 
is affected, the other components of the joint will be affected secondary (Flugsrud et al., 
2010).  
Figure 1: Characteristics of an osteoarthritic knee. Reproduced with permission from Hunter (2011). 
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We can divide osteoarthritis into three stages. The early stage of osteoarthritis is marked 
by morphological changes in the otherwise-smooth and well-lubricated articular 
cartilage that covers the joint surfaces (Sovani & Grogan, 2013). In the mid stage 
increased cell death and homeostatic imbalance leads to increased catabolic mediator 
activity and degradation of the extracellular matrix. Progression of the mid stage will 
finally end in cartilage destruction. In the late stage of osteoarthritis a hallmark is the 
formation of cell clusters containing cells that indicate a hopeless attempt of tissue 
regeneration (Sovani & Grogan, 2013). 
Traditionally, loss of cartilage has been the main focus of osteoarthritis (Altman et al., 
1986). However, because osteoarthritis involves all tissue of the synovial joint the 
emphasis on the loss of cartilage is misguided (Brandt, Dieppe, & Radin, 2008). 
Osteoarthritis could be viewed as failed repair of damage that has been caused by 
excessive mechanical stress on joint tissue. 
Inflammation is present in an osteoarthritic joint to a variable extent, however how 
much the inflammation contributes to joint damage is questionable (Felson, 2013). 
Likely, the basis of the joint damage in osteoarthritis is caused by mechanically induced 
injury according to Felson (2013). Evidence shows that injury to the joint can lead to 
secondary inflammation. Also, treatment to correct mechanics has been superior to 
treatment to correct inflammation. Thus, inflammation in osteoarthritis is most likely a 
consequence of pathomechanics (Felson, 2013). Joint injury could cause joint damage 
without involvement from the inflammation, however the inflammation can accelerate 
or magnify the injury that is produced by pathomechanics. While inflammation is likely 
contributing to further destruction of the osteoarthritic joint, abnormal mechanics is the 
basis of osteoarthritis claims Felson (2013). On the other hand according to Berenbaum 
(2013) recent findings arguments in favor of osteoarthritis as an inflammatory disease. 
Low-grade inflammation induced by the metabolic syndrome, innate immunity and 
inflammaging are among these arguments.      
The aetiology of osteoarthritis is perhaps best understood as a result of excessive 
mechanical stress applied in the context of systemic susceptibility (Hunter, 2011). 
Nevertheless, the pathophysiology of osteoarthritis is still not fully understood 
(Buckwalter & Martin, 2006).   
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3.5 Risk factors 
Risk factors for osteoarthritis could be divided into modifiable and non-modifiable risk 
factors. We can possibly influence the modifiable risk factors in clinical practice, and it 
is only by understanding the impact of the disease and the modifiable risk factors that 
we will truly be able to target public health preventions appropriately (Johnson & 
Hunter, 2014). 
3.5.1 Non-modifiable risk factors 
Age is a risk factor for developing osteoarthritis, and the prevalence of the disease is 
increasing with increasing age (Chaganti & Lane, 2011). It is thought that aging have an 
adverse effect on the ability of the joint to protect itself from biomechanical stress.  
Large database studies have shown that different ethnicities have different prevalence of 
osteoarthritis (Chaganti & Lane, 2011). Difference in sex is also observed, the 
prevalence among woman are higher than among men. Furthermore, genetics seems to 
play a role. Twins studies have indicated that as much as 40-60% of all incidences of 
idiopathic osteoarthritis are due to genetics (Valdes & Spector, 2009). 
3.5.2 Modifiable risk factors 
The two best documented risk factors for osteoarthritis are obesity and joint injury 
(Johnson & Hunter, 2014). The risk factors show some variation depending of 
localization. Osteoarthritis of the knee are associated with obesity, but also osteoarthritis 
of the hip and hand show association with obesity even though this association is 
weaker than for the knee (Magliano, 2008). The association between hand osteoarthritis 
and obesity indicates that biomechanics alone does not fully explain the reason. 
Hormonal or nutritional factors are suggested as the reason why obesity is linked to the 
risk of osteoarthritis, without any conclusive documentation to support this theory 
(Grundy et al., 2005). In addition the increased load obesity cause is thought to be 
contributing. During gait, each additional kilogram of body mass increases the 
comprehensive load over the knee by roughly four kilogram (Messier, Gutekunst, 
Davis, & DeVita, 2005). 
Hence, the question whether mechanical or systemic factors are most important for 
developing osteoarthritis has been raised (Cicuttini & Wluka, 2014). Han et al. (2013) 
17 
 
found no association between metabolic syndrome and knee osteoarthritis in their study. 
Contrary, Monira et al. (2014) did find an association between metabolic syndrome and 
knee osteoarthritis. In the study by Visser et al. (2014) mechanical stress were found to 
be the most important risk factor for knee osteoarthritis, whereas systemic factors were 
found to be the most important risk factor for hand osteoarthritis.   
Injuries, especially of the knee are predisposing to osteoarthritis (Johnson & Hunter, 
2014). The numbers in the literature vary, however there are consensus that the risk of 
osteoarthritis increases after traumatic knee injuries and the surgery that often follows 
these injuries. Sports activities itself does not seem to increase the risk of osteoarthritis, 
as long as the intensity are at a moderate to low level (Hunter & Eckstein, 2009). In 
contrast, elite sports participation seems to be associated with increased risk of 
osteoarthritis. The nature of the sport is very important to the degree of risk though, and 
it is not clear whether participation in elite sport in the absence of injury is harmful. 
Physical activity seem to be safe for the knee joint, however very high levels and high 
force  is a potential risk of developing osteoarthritis (Ratzlaff, Koehoorn, Cibere, & 
Kopec, 2012). Joint tissue are sensitive to their mechanical environment, and moderate 
mechanical loading maintains the integrity of articular cartilage, while disuse and 
overuse can result in cartilage degradation (Sun, 2010). Repetitive joint use such as 
kneeling and squatting are increasing the risk of osteoarthritis (Johnson & Hunter, 
2014), and studies have found individuals whose occupations require this have twice the 
risk of developing knee osteoarthritis compared with occupations without these physical 
demands (Messier et al., 2009). 
Other potential risk factor for knee osteoarthritis are weakness of quadriceps femoris 
and knee malalignment (Johnson & Hunter, 2014). Moreover, anatomical abnormalities 
are associated especially with hip osteoarthritis (Chaganti & Lane, 2011).   
3.6 Pain and symptoms 
Pain is the dominant symptom of osteoarthritis, and the main reason patients seek 
medical help (Bijlsma et al., 2011). Loss of movement and function is another major 
problem for osteoarthritis patients, and are closely associated to the level of pain 
(Hutchings et al., 2007). This may limit patients in activities of daily living such as stair 
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climbing, walking and doing household chores. Muscle atrophy is seen secondary to 
inactivity (Stemberger & Kerschan-Schindl, 2013). Stiffness is also a common 
symptom, however this stiffness generally resolves in minutes unlike the prolonged 
stiffness caused by rheumatoid arthritis (Bijlsma et al., 2011). The stiffness is 
experienced in the morning, after a period of inactivity, or in the evening, and lasts 
usually less than 30 minutes.  
Joint enlargement results from joint effusion, bony swelling, or both, and may be seen 
in patients with osteoarthritis (Bijlsma et al., 2011). Crepitus, a sensation of crunching 
or crackling, is commonly felt on passive or active movement of an osteoarthritic joint. 
If loose bodies or fragments of cartilage get into the joint space, the joint can lock. 
Moreover, an osteoarthritic joint could be instable, buckling or giving way (Hunter et 
al., 2009). The rest of this chapter will be focusing on the most dominant symptom in 
osteoarthritis patients, which is pain. 
3.6.1 Pain 
Pain is defined by the International Association of the study of Pain as an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or 
described in terms of such damage (Merskey & Bogduk, 1994). According to this 
definition, cognitive and emotional aspects are always involved in a pain experience. 
Pain might vary in intensity (mild, moderate, or severe), quality (sharp, burning, or 
dull), duration (transient, intermittent, or persistent), and referral (superficial or deep, 
localized or diffuse) (Woolf, 2004). Mechanisms behind pain could be several including 
nociception, peripheral sensitization, phenotypic switches, central sensitization, ectopic 
excitability, structural reorganization, and decreased inhibition.  
Pain is often classified according to the duration: acute pain and chronic or persistent 
pain (Woolf, 2004). Acute pain contributes to survival by protecting us from injury or 
promoting healing when injury has occurred. Chronic or persistent pain is defined by 
the International Association for the study of Pain as pain that persists past the healing 
phase following an injury (IASP, 1986). The first type of pain is adaptive, while the 
latter is clearly maladaptive (Woolf, 2004). To determine the end of the healing phase is 
difficult, however the common clinical definition is instead a fixed time of persistent 
pain following its initial onset (Apkarian, Baliki, & Geha, 2009). Usually this time is set 
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to three or six months, although it is difficult to classify one time period for all different 
pain conditions. 
3.6.2 How pain manifests in patients with osteoarthritis 
Typically osteoarthritis presents as joint pain which is exacerbated by activity and 
relieved by rest (Hunter et al., 2009). The most prominent symptom in patients with 
osteoarthritis is pain, which fluctuates over time and across different activities 
(Dimitroulas, Duarte, Behura, Kitas, & Raphael, 2014). In periods osteoarthritis patients 
might experience acute flare-up of pain, for example after a high load of activity  
(Hunter et al., 2009). In later stages of osteoarthritis, pain can be experienced at rest and 
during the night. The pain is often described as deep aching, and not well localized. In 
the past osteoarthritis pain has been considered relatively stable other than changes with 
activity and rest (Allen et al., 2009). However, the literature showing pain fluctuations 
in patients with osteoarthritis is growing. 
In a focus group study (Hawker et al., 2008) patients described two distinct types of 
pain as their disease progressed. The first pain was described as dull, aching, throbbing, 
which became more constant over time. The second pain was described as more intense, 
often unpredictable, and emotionally draining. Furthermore, patients described their 
pain as worsening over time which was expected. They also distinguished their 
experience of pain depending of the progression of the disease. In the early stage of 
osteoarthritis pain was characterized by predictable sharp pain, usually brought on by a 
trigger which could be an activity such as sport. Eventually the pain limited high impact 
activities such as skiing, but had relatively little other impact (Hawker et al., 2008). 
In the mid stage of osteoarthritis, the patients described the predictable pain as 
increasing and the pain become more constant (Hawker et al., 2008). The pain started to 
affect activities of daily living such as walking and climbing stairs. In the advanced 
stages of osteoarthritis a constant dull and aching pain with short episodes of often 
unpredictable intense pain was described. The time from the insidious onset of pain 
until the advanced stage with a constant dull and aching pain were usually several years 
(Hawker et al., 2008).    
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Allen et al. (2009) examined within-day pain patterns in patients with osteoarthritis. 
They found pain patterns to differ substantially across individuals. Furthermore, patients 
reported a significant range of pain scores within a day, with a mean range of about 35 
points between maximum and minimum ratings on a scale from 0-100. Pain was 
measured on one weekday and one weekend day using a handheld computer, with 
ratings beginning immediately after waking then approximately every two hours 
following. A sliding visual analog scale with a hidden coding of 0-100 was used to rate 
the pain. Bellamy et al. (2002) also found pain to change within a day in patients with 
hand osteoarthritis. Participants self rated pain on a 10 cm horizontal visual analogue 
scales six times a day for ten consecutive days. Pain was found to change systematically 
throughout the day, showing circadian rhythmicity.  
The Longitudinal Examination of Arthritis Pain study examined pain variations on a 
weekly basis in adults diagnosed with hip or knee osteoarthritis (Hutchings et al., 2007). 
Participants reported pain levels and other health outcome measures through weekly 
telephone interview for twelve weeks. Weekly pain ratings on an 11-point scale (0=no 
pain, 10=extreme pain) indicated within-week pain fluctuation of about two points. In 
addition, decreases in the patient reported pain were associated with improvements in 
daily activities and decreases in work absenteeism, sleep interference, and healthcare 
resource use. These results were showing the importance of the small changes in pain 
levels (Hutchings et al., 2007). 
Pain was described as changing month by month, day by day, and by the time of the day 
in a qualitative study of patients with hip and knee osteoarthritis (Gooberman-Hill et al., 
2007). Patients took part in six focus groups describing and discussing their experience 
of joint pain in the context of the questionnaires Hip Disability and Osteoarthritis 
Outcome score and Knee Injury and Osteoarthritis Outcome score. The focus groups 
were audio recorded and transcribed. Data were analyzed resulting in the identification 
of key categories. Patients characterized their pain in these four key categories: “pain is 
intermittent and variable”, “pain elsewhere in the body influences the experience of 
joint pain”, “pain is inextricable from function”, and “adaptation and avoidance 
strategies modify the experience of pain”. Although pain has been shown to fluctuate on 
a daily (Allen et al., 2009; Bellamy, Sothern, Campbell, & Buchanan, 2002), weekly 
(Hutchings et al., 2007) and monthly (Gooberman-Hill et al., 2007) basis, the amount of 
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research done in this area is relatively scarce (Allen et al., 2009). Thus the knowledge 
about pain fluctuations in patients with osteoarthritis is still limited.  
3.6.3 Biopsychosocial model of osteoarthritis pain 
Historically, cartilage damage was believed to be the main reason for the pain 
experienced in people with osteoarthritis (Sofat et al., 2011). Hence, nociceptive pain 
was considered the primary type of pain in osteoarthritis (Dimitroulas et al., 2014). 
Although cartilage damage still is assumed to be an important factor in the disease 
progress of osteoarthritis, there is increased knowledge regarding the fact that several 
other factors are influencing the pain experience. Both inflammatory and neuropathic 
pain has been shown to be contributing to the pain experience. 
At present, there is research clearly indicating that there is a discordance between 
radiographic knee osteoarthritis and the pain experienced (Bedson & Croft, 2008), 
although the discordance is less with more severe stages of radiographic disease (Neogi, 
2013). Magnetic resonance imaging seem to predict clinical pain better than x-rays 
(Staud, 2011). Nevertheless, radiographic imaging cannot be used solely to predict 
osteoarthritis pain (Cibere, 2006). This is adding to the understanding that the pain 
experienced with osteoarthritis might not only be due to biomedical reasons. Why there 
is disconnect between disease severity in form of joint degeneration and the level of 
pain experienced, is not fully understood (Hunter et al., 2009). 
Thus a shift from the traditional biomedical view of the pain experience in osteoarthritis 
towards a biopshycosocial is needed (Hunt, Birmingham, Skarakis-Doyle, & 
Vandervoort, 2008). The biopsychosocial model also includes the biomedical part, but 
in addition psychological factors and social factors are taken into account. How people 
cope with the osteoarthritis pain may vary, hence psychosocial factors might possibly 
affect how patients experience the osteoarthritis pain. 
The evidence for the importance of psychosocial variables in explaining osteoarthritis 
pain is emerging (Somers, Keefe, Godiwala, & Hoyler, 2009). Especially cognitive 
variables such as pain catastrophizing and self-efficacy show consistent links to pain. 
Social support and pain communication are also important considerations in 
understanding the pain experience (Hunter, Guermazi, Roemer, Zhang, & Neogi, 2013). 
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Other psychosocial factors like environment and employment play a substantial role in 
determining the level of disability and pain (Hunt et al., 2008). All this add to the 
perception that osteoarthritis should be viewed in a biopsychosocial framework, and 
addressing all the dimensions is of importance when pain is to be explained and 
managed.  
 
Figure 2: Biopsychosocial model highlighting the relation of structural pathology to the pain experience. 
The model shows that there are many variables behind the pain experience. Reproduced with permission 
from Hunter et al. (2013).  
3.6.4 Potential pain mechanisms in osteoarthritis 
Despite pain being the primary symptom and main cause of disability, much remains to 
be clarified about the potential mechanisms behind osteoarthritis pain (Mease, Hanna, 
Frakes, & Altman, 2011). The following paragraphs give a summary of potential 
mechanisms underlying the pain experience in patients with osteoarthritis. 
Nociception 
Activation of specialized sensory neurons called nociceptors lead to the sensation of 
pain (Murphy, Phillips, Williams, & Clauw, 2012). Usually, activation of nociceptors 
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only occurs in the presence of a noxious stimulus. Although abnormal cartilage damage 
is a key hallmark of osteoarthritis, cartilage is avascular and hence aneural (Mease et al., 
2011). Nociceptors are accordingly not found in cartilage, and damaged articular 
cartilage is therefore not capable of directly generating pain in osteoarthritis (Felson, 
2005). However, there are several other structures in the joint with nociceptors (see 
paragraphs below). 
Worth noticing is that according to a review of Sofat et al. (2011) previous literature 
describing cartilage entirely avascular and aneural has recently been challenged, 
suggesting modifications occur during osteoarthritis disease. A study by Suri et al. 
(2007) demonstrated that a substantial number of fine nerve terminals may be present in 
osteoarthritic cartilage. Studies have demonstrated a relation of cartilage damage to 
pain, however the likely mechanisms for symptom genesis are through secondary 
mechanisms that comes along with the cartilage damage according to Hunter et al. 
(2013). Other structures in the synovial joint are innervated by nociceptors, and these 
are the likely source for the pain experienced in these studies claims the author. 
Periarticular bone changes associated with osteoarthritis are among these mentioned 
other structures in the synovial joint, which are potential sources for  the pain 
experienced (Hunter et al., 2013). Changes include progressive increase in subchondral 
plate thickness, alterations in the architecture of subchondral trabecular bone, formation 
of new bone at the joint margins (osteophytes), development of subchondral bone cysts 
and advancement of the tidemark associated with vascular invasion of the calcified 
cartilage.  
Bone marrow lesions are the osseous change with most supportive evidence for a role in 
symptom genesis (Hunter et al., 2013). According to Hunter et al. (2013) there is some 
conflicting data, however the balance of data would support a strong relation between 
bone marrow lesions and pain in osteoarthritis. Other bone related causes of pain are 
periostitis associated with osteophyte formation, subchondral microfractures, bone 
attrition and bone angina due to decreased blood flow and elevated intraosseous 
pressure. 
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Synovitis and effusion are also often present in an osteoarthritic joint, and are correlated 
to pain (Hunter et al., 2013). Included in the synovial reaction in osteoarthritis is 
synovial hyperplasia, fibrosis thickening of synovial capsule, and activated 
synoviocytes (Roach, Aigner, Soder, Haag, & Welkerling, 2007). The presence or 
absence of synovitis may even be an independent predictor of pain experienced in 
osteoarthritis (Bonnet & Walsh, 2005). However, the exact contribution of 
inflammation to pain in osteoarthritis is uncertain and may vary from time to time and 
from patient to patient. It is today unclear whether inflammation is a feature of all 
patients with osteoarthritis at some stage of their disease process, or whether synovitis 
itself defines one subgroup of the osteoarthritis disease.  
Another potential source of pain in osteoarthritis is the outer rim of the meniscus, which 
is innervated (Ashraf et al., 2011). Meniscal damage is a common feature of knee 
osteoarthritis, however the clinical relevance are unclear. In a study by Bhattacharrya et 
al. (2003) a meniscal tear was found in 76% of asymptomatic patients with a mean age 
of 65 years using MRI, whereas 91% of patients with symptomatic knee osteoarthritis 
had a tear. Thus the clinical relevance of meniscal tears in elderly patients with knee 
osteoarthritis may be limited (Hunter et al., 2013). Other tissues such as periostium, 
periarticular ligaments, and perarticular muscles spasm are richly innervated and are all 
potential sources of nociception in osteoarthritis (Hunter et al., 2009).    
Peripheral sensitization   
When tissue injury occurs, it leads to an inflammatory response with release of 
inflammatory mediators (Staud, 2011). Inflammation in the joint trigger a cascade of 
events leading to increased sensitivity of nociceptive neurons, which we call peripheral 
sensitization (Mease et al., 2011). The threshold of nociceptive neurons are lowered, 
hence nociceptors respond to non-noxious stimuli (allodynia) and the response to 
noxious stimuli is exaggerated (hyperalgesia). Gentle stimuli which normally do not 
activate them, might be sufficient to excite the nociceptors (Schaible, Schmelz, & 
Tegeder, 2006). 
As the cartilage in osteoarthritis is destroyed,  inflammatory mediators are released 
(Haringman, Ludikhuize, & Tak, 2004). Inflammation triggers as mentioned a cascade 
of events driven by the inflammatory mediators, leading to enhanced cartilage turnover 
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and matrix degradation (Dimitroulas et al., 2014). There are many degenerative 
structural changes within the joint in osteoarthritis other than cartilage damage, which 
can trigger inflammation. Especially bone marrow lesion, synovitis and effusion have 
been recognized (Hunter et al., 2013). When the disease progresses, more of these 
mediators accumulate in the joint, hereby triggering a self-perpetuating cycle of pain 
generation (Hunter et al., 2009).  
One proposed hypotheses suggests osteoarthritis as an autoinflammatory disease 
(Konttinen, Sillat, Barreto, Ainola, & Nordstrom, 2012). The articular cartilage can 
produce substances that are able to cause pain and secondary inflammation, and this 
mechanism suggests that osteoarthritis could be considered as an autoinflammatory 
disease.  
In addition to the sensory neurons nociceptors, so-called silent nociceptors exist 
(Schaible et al., 2006). These neurons are not activated as long as the tissue is normal, 
however when the tissue is inflamed these silent nociceptors are sensitized and they 
start to respond. The awakening of the silent nociceptors is assumed to contribute to 
intensifying joint pain sensation in arthritis (Hunter et al., 2009). 
Central sensitization 
Central nociceptive transmission in the dorsal horn can also be sensitized like the 
peripheral nociceptors (Hunter et al., 2009). The threshold for activation falls and 
responses to sequent inputs are amplified (Latremoliere & Woolf, 2009). When central 
sensitization is present pain could arise spontaneously, be elicited by normally 
innocuous stimuli (allodynia), have prolonged and exaggerated response to noxious 
stimuli (hyperalgesia), spread beyond the site of injury (secondary hyperalgesia), and 
even be widespread according to Latremoliere & Woolf (2009).  It should be known 
that there are different opinions in the literature around the phenomenon central 
sensitization, and to what extent this phenomenon is the mechanism behind pain seen in 
the clinic (Hansson, 2014). 
It is believed that peripheral sensitization play an important role in the development and 
maintenance of central sensitization (Mease et al., 2011). Repeated input from 
peripheral nociceptors modulate nociceptors in the spinal cord leading to increased 
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synaptic excitability and decreased firing threshold (Scholz & Woolf, 2002). Central 
sensitization has both spinal and supraspinal components (Schaible, 2012). Depression 
of spinal inhibitory mechanisms are also contributing to pain experience (Woolf & 
Salter, 2000). When the inhibitory mechanisms are not working properly, the pain 
experience is amplified (see figure 3). Another phenomenon termed windup are a result 
of abnormal repetitive stimulation of a peripheral nociceptors, which also contributes to 
pain intensifying (Dimitroulas et al., 2014). 
3.6.5 Pain assessment 
Numerous assessment tools have been developed for assessing level and quality of pain, 
and its impact on function (Turk & Melzack, 2011). Having a valid and reliable 
assessment of pain is essential for both clinical trials and effective pain management. 
Location, intensity and the frequency of pain are the dimensions of pain most often 
measured. The nature of pain however, makes objective measurement impossible. 
Hence, subjective assessment of pain in form of questionnaires, rating scales, and pain 
drawings is the common way of assessing pain.  
Each assessment tool has its own strength and weaknesses (Hawker, Mian, Kendzerska, 
& French, 2011). Visual Analog Scale and Numeric Rating Scale (NRS) are generic 
unidimensional single-item scales providing estimates of patients self-reported level of 
pain intensity. Positive for these two assessment tools are that they are easy to 
administer, complete, and score. However, they are not providing a comprehensive 
evaluation of pain in patients with rheumatic disease (Hawker et al., 2011). 
To meet the complexity of pain and to assess the multiple dimensions of acute and 
chronic pain, multidimensional questionnaires like The McGill Pain Questionnaire and 
The Chronic Pain Grade Scale have been developed (Hawker et al., 2011). These 
questionnaires contain questions to not only describe the quantity of pain, but also the 
quality. The Short Form-36 Bodily Pain Scale is another multidimensional 
questionnaire, which evaluates pain in a context of the overall health status. These 
multidimensional questionnaires are however, not as easy to administer, complete, and 
score as the unidimensional questionnaires (Hawker et al., 2011). 
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More disease specific questionnaires have been developed to even better measure the 
pain experienced. For osteoarthritis the Knee Injury and Osteoarthritis Outcome Score 
(KOOS) has been developed as an osteoarthritic-specific pain measure and is even joint 
specific (Roos, Roos, Lohmander, Ekdahl, & Beynnon, 1998). Western and Ontario and 
McMaster Universities Index of Osteoarthritis (WOMAC) (Bellamy, Buchanan, 
Goldsmith, Campbell, & Stitt, 1988) and Measure of Intermittent and Constant 
Osteoarthritis Pain (Hawker et al., 2011) are also two disease specific questionnaires. 
Due to the variability and complexity of pain, and the variability in purpose, content, 
administration burden, and evidence to support each measurement method, no pain 
measure can be recommended for use in all situations (Hawker et al., 2011).   
Studies including patients with osteoarthritis have found that health outcomes and the 
course of disease progression are related to a patient’s self-efficacy (Felson et al., 2000; 
Brekke, Hjortdahl, & Kvien, 2003). Perceived self-efficacy is defined by Bandura 
(1986) as “ Peoples’ judgment of their capabilities to organize and execute courses of 
action required to attain designated types of performance” . It is concerned not with the 
skill one has, but measures a changeable psychological aspect of pain (Lorig, Chastain, 
Ung, Shoor, & Holman, 1989). Arthritis Self-Efficacy Scale (Lorig et al., 1989) is a 
questionnaire developed to measure this dimension. 
3.7  Treatment 
There is no known cure for osteoarthritis (Stemberger & Kerschan-Schindl, 2013). 
Management of osteoarthritis is in international recommendations often divided into 
three main categories: non-pharmacological, pharmacological and surgical (Zhang et al., 
2010). Because till now osteoarthritis is an irreversible condition, the overall treatment 
goal is to reduce pain and to improve function while minimizing the potentially harmful 
side effects of medications and potentially reduce progression of the disease (Zhang et 
al., 2007). Improving health-related quality of life is also of essential interest 
(Stemberger & Kerschan-Schindl, 2013). The treatment should be individualized 
keeping in mind the patients demands, but the treatment options are diverse (Stemberger 
& Kerschan-Schindl, 2013). See figure 3 for a summary of treatment options for 
osteoarthritis. The emphasis of this theory chapter is non-pharmacological treatment of 
knee osteoarthritis.  
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3.7.1 Non-pharmacological treatment 
Exercise 
Exercise is recommended as treatment for osteoarthritis thoroughly in international 
guidelines (McAlindon et al., 2014; Hochberg et al., 2012; Fernandes et al., 2013). A 
Cochrane review (Fransen et al., 2015) investigating exercise for osteoarthritis of the 
knee revealed a beneficial effect with a standardized mean difference of 0.49  for pain 
and 0.52 for physical function. These effect sizes are in line with effect sizes reported 
for non-steroidal and anti-inflammatory drugs. The authors conclude that high-quality 
evidence indicate that land-based therapeutic exercise provides short term benefit in 
terms of reduced knee pain and improved physical function among people with knee 
osteoarthritis (Fransen et al., 2015). This conclusion is in accordance with an overview 
of systematic reviews in patients with knee osteoarthritis (Jamtvedt et al., 2008), which 
found high quality evidence for exercises having small to moderate effect in this patient 
group. 
Included in recommendations are exercises to improve flexibility, strength and 
endurance, although there is conflicting evidence for mixed exercise programs being 
more effective than focused programs (Fernandes et al., 2013). One type of exercise has 
not been shown to be superior to another. According to a systematic review (Juhl, 
Christensen, Roos, Zhang, & Lund, 2014) optimal exercise programs for osteoarthritis 
should have one aim, and focusing on improving aerobic capacity, quadriceps muscle 
strength, or lower extremity performance. A review by Bennel et al. (2013) 
investigating the role of muscle in the genesis and management of knee osteoarthritis 
concludes that exercise to improve lower limb strength and especially the quadriceps 
muscle is a key component in the management. The form of exercise may be supervised 
group classes, as individual treatment with a physiotherapist, or unsupervised at home 
(Stemberger & Kerschan-Schindl, 2013). All three treatment forms mentioned achieve 
significant treatment benefits, however the number of directly supervised exercise 
sessions influences treatment effect sizes (Fransen & McConnell, 2008). For best 
results, the program should be supervised and carried out three times a week according 
to Juhl et al. (2014). 
There are need for more documentation regarding optimal exercise intensity and 
frequency (Oiestad et al., 2013). At present time we know too little about dose-response 
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relationship in exercise interventions on patients with osteoarthritis (Wang et al., 2012). 
Adherence to exercise is another important factor to the efficacy, and Wang et al. (2012) 
showed a possible association between high adherence to exercise and improved pain 
and function in knee. 
Despite the overwhelming evidence for the effectiveness of exercise for osteoarthritis of 
the knee, underlying mechanisms of these beneficial exercise-induced effects are still 
scarcely understood (Beckwee et al., 2013). In a review by Beckwee et al. (2013) the 
authors identified theories that are proposed in the scientific literature to explain the 
beneficial effects of exercise on osteoarthritis of the knee. They were able to identify 
five main categories of components that are proposed to potentially explain the 
effectiveness of exercise: neuromuscular components, peri-articular components, intra-
articular components, general fitness and health components, and psychosocial 
components.  
In the neuromuscular components category, the proposed underlying mechanisms for 
the beneficial effect of exercise are mainly focused on the decrease of the mechanical 
focal peak loading of the cartilage due to the impact of exercise on these components 
(Beckwee et al., 2013). Mentioned neuromuscular components are muscle strength, 
proprioception and motor learning, energy absorbing capacity and stability. However it 
should be mentioned that in misaligned and lax or unstable osteoarthritis knees, high 
quadriceps strength is a significant risk factor for radiographic progression of 
osteoarthritis according to Sharma et al. (2003). 
Exercise is suggested to have a positive effect on periarticular components such as 
connective tissue and bone. Neither rationale, scientific evidence or through which 
pathway exercise has an effect on these components are clear (Beckwee et al., 2013). 
Among intra-articular components that exercise is proposed to have a beneficial effect 
on are cartilage, inflammation, and joint fluid. 
When it comes to the general fitness and health components it is not well described how 
exercise has effect on osteoarthritis of the knee via these components, other than 
exercise is good for fitness and health in general (Beckwee et al., 2013). In the last 
category psychosocial components, authors (O'Reilly, Muir, & Doherty, 1999; Rogind 
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et al., 1998) have suggested that exercise may influence symptoms through an 
enhancement of general well-being. Increase of self-efficacy, decrease of depression 
and placebo effects are other psychosocial components suggested to be effected of 
exercise (Beckwee et al., 2013).   
Aquatic exercise has also shown to be beneficial for knee osteoarthritis in short term, 
but no long term effects have been documented (Bartels et al., 2007). The effect of 
water minimizes joint load, hence aquatic exercises seems particularly useful in the 
initial phase of exercising. However, the number of studies investigating aquatic 
exercise for knee osteoarthritis is low and the level of evidence on the existing studies is 
poor. A Cochrane review (Bartels et al., 2007) found only four studies meeting the 
criteria of inclusion for the review, and only one study was acceptable for analysis of 
knee osteoarthritis alone. Effect sizes of hip and knee osteoarthritis was not possible to 
separate in the other studies. 
In summary, exercise should in general be recommended to patients suffering from knee 
osteoarthritis (Stemberger & Kerschan-Schindl, 2013). Whether exercise is a cost-
effective intervention is still an open question (Hagen et al., 2012). 
Weight reduction 
Weight loss is especially recommended for overweight patients with knee osteoarthritis 
(Stemberger & Kerschan-Schindl, 2013). When we know that obesity is one of the 
biggest risk factors for osteoarthritis (Johnson & Hunter, 2014), it is easy to understand 
that weight reduction is beneficial as treatment for this patient group. One major reason 
for this is the reduced joint load (Bliddal, Leeds, & Christensen, 2014). Messier et al. 
(2005) found that for every kilogram of bodyweight lost, a fourfold reduction in the 
load exerted on the knee per step during daily activities is achieved. Taken into 
consideration thousands of steps taken every day, a reduction of this magnitude appear 
to be clinically meaningful (Messier et al., 2005).    
Weight loss can relieve symptoms, improve function, increase quality of life, and in 
addition be preventive of osteoarthritis (Bliddal et al., 2014). The combination of 
exercise with weight loss appears to be more effective than either intervention alone for 
obese patients with knee osteoarthritis (Messier et al., 2004). 
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Education and self-management 
It is a general recognition that appropriate information and education are essential in 
prompting adequate self-management in chronic diseases (Fernandes et al., 2013). 
According to a systematic review of recommendations and guidelines for the 
management of osteoarthritis 12 out of 15 guidelines had moderate to strong 
recommendations for self-management programs and education (Nelson, Allen, 
Golightly, Goode, & Jordan, 2014). A self-management program are recommended to  
include education about osteoarthritis, regular contact to promote self-care, joint 
protection strategies, evaluation of ability to perform activities of daily living, 
psychosocial interventions, and individualized treatment plans. Somewhat contrary, a 
Cochrane review found low to moderate evidence that self-management programs result 
in no or small benefits in patients with osteoarthritis (Kroon et al., 2014). According to 
the review self-management programs do not result in more positive and active 
engagement in life compared with usual care. Although the review concludes that self-
management skills, pain, osteoarthritis symptoms and function may improve, the 
apparent benefits are small and unlikely to be of clinical importance according to the 
authors (Kroon et al., 2014).  
Assistive devices 
There is a general lack of agreement among guidelines regarding patellar taping, knee 
braces, medial and lateral heel wedges, and appropriate footwear and/or insoles for 
patients with knee osteoarthritis (Nelson et al., 2014). Walking aids and other assistive 
devices to improve activities of daily living are generally recommended. According to 
OARSI guidelines (McAlindon et al., 2014) biomechanical interventions as directed by 
an appropriate specialist, are recommended.  
Physical modalities  
Thermal modalities are recommended for knee osteoarthritis (Nelson et al., 2014), while 
there are uncertainty regarding the effect of transcutaneous electrical nerve stimulation 
(TENS) and ultrasound (McAlindon et al., 2014). Electrotherapy or neuromuscular 
electrical stimulation does not have appropriate documentation to be recommended. 
32 
 
3.7.2 Pharmacological treatment 
We are lacking pharmacological treatment decelerating or reversing the cartilage 
degeneration in osteoarthritis, hence pharmacological treatment aims to reduce 
symptoms (Zhang et al., 2007). According to a review of guidelines 
acetaminophen/paracetamol should be used as first-line pharmacological management 
of osteoarthritis, while second line agents should include topical agents and oral 
NSAIDs (Nelson et al., 2014). Intra-articular corticosteroids are recommended for knee 
osteoarthritis, however there are insufficient evidence currently existing to provide a 
general recommendation regarding intra-articular hyaluronans.  
3.7.3 Surgical treatment   
Surgical treatment may be preventive or as part of symptom treatment when 
osteoarthritis has become severe (Flugsrud et al., 2010). When conservative treatment 
fails, surgical treatment such as joint replacement are considered (Singh, Dohm, & 
Borkhoff, 2013). Joint replacement is recommended for appropriate patients with knee 
osteoarthritis, normally at the end stages of the disease (Nelson et al., 2014). Total knee 
joint replacement and total hip joint replacement are associated with significant 
improvement in pain, function, and quality of life and are universally recommended in 
guidelines (Rhon, 2008). Joint replacement surgery is generally accepted as reliable and 
appropriate surgical procedure to restore function and to improve pain and quality of 
life when other treatments fail. At the end stage of knee and hip osteoarthritis this type 
of management achieves by far the most significant treatment effects. On the other hand 
arthroscopy with debridement is not recommended (Nelson et al., 2014). 
3.7.4 Summary 
First line treatment of osteoarthritis should contain information, advice and self-help 
(Lohmander & Roos, 2007). Included in these recommendations are education about 
weight loss, exercise, lifestyle alterations, simple analgesics and topical agents (see 
figure 3). Exercise and weight management are key elements in the conservative 
treatment of osteoarthritis. Pharmacological management and other non-surgical 
interventions such as orthoses could also be considered. If these treatment options are 
not sufficient, surgical treatment with joint replacement could then be considered 
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(Hunter & Felson, 2006). Individualizing the treatment to the patients demands is of 
importance and should be a certainty (Stemberger & Kerschan-Schindl, 2013).  
 
Figure 3: Overview of treatment options for osteoarthritis depicting the number of people that need each 
treatment. Reproduced with permission from Lohmader & Roos  (2007). 
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4. Methods 
This chapter will describe the study process and the assessment methods that were used.    
4.1 Design 
This master’s thesis was a single subject design, also referred to as single system 
design, small-N design or idiographic research design (Ottenbacher & York, 1984). 
Single subject designs are an alternative to group designs, and may provide concrete 
data to validate existing theories as well as formulating new ones (Backman, Harris, 
Chisholm, & Monette, 1997). The term single subject refers to the treatment of the data 
and not to the number of participants in the study (Carter, Lubinsky, & Domholdt, 
2011). The data from each research participant are analyzed separately and not as a 
group. The single subject design focus on individuals makes the research method ideally 
suited to document clinical change on an individual basis (Ottenbacher & York, 1984). 
By choosing single subject design we could therefore obtain information from the 
individual patient.  
Single subject designs are characterized by extended periods of measurements through 
repeated measurements both in the baseline phase, the intervention phase, and the post 
intervention phase (Carter et al., 2011). Generally at least three measurements are 
recommended at any phase during the research, including the baseline phase. We had in 
our study seven assessments at the baseline phase, 14 assessments during the 
intervention phase, and seven assessments at the post intervention phase. The 
continuous assessments through the different phases (baseline, intervention, and post 
intervention phase) give information that can be used to monitor patient changes (linear 
trends and cyclic patterns) as well as progression during an intervention phase 
(Ottenbacher & York, 1984). Another characteristic of single subject designs are the 
lack of a control group (Engel & Schutt, 2005). The subject serves as their own control, 
as the repeated baseline measurements establish the pattern of scores that we expect the 
intervention to change.  
Patients already participating in a randomized controlled trial (Oiestad et al., 2013) were 
followed over a 16 week period as part of this study. They were asked to answer 
questionnaires regularly throughout this period. At baseline of this 16 week period, 
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patients were interviewed daily by telephone for one week. They were afterwards 
contacted weekly during the 14 week intervention period (two weeks introduction + 
twelve weeks intervention). After intervention was completed in the randomized 
controlled trial, patients were again contacted daily for one week making it a total of 16 
weeks (1 week baseline assessment + 14 week intervention assessment + 1 week post 
intervention assessment) (see figure 4).  
4.2 Subjects 
Subjects already participating in the randomized controlled trial (Oiestad et al., 2013) 
were recruited to this study. The recruitment process started 1
st
 of August 2014 and was 
finished on the 31
st
 of December 2014. From August 2014 the consecutively included 
patients in the randomized controlled trial were evaluated for eligibility in this master’s 
thesis. 
Table 3: Inclusion and exclusion criteria in the randomized controlled trial (Oiestad et al., 2013).   
Inclusion Exclusion 
 Woman and men aged 45-65 years 
 Clinical knee osteoarthritis according 
to the American College of 
Rheumatology Clinical Criteria (Altman 
et al., 1986) 
 Kellgren and Lawrence (KL) 
radiographic osteoarthritis grade 2 and 
3 (mild to moderate radiographic 
osteoarthritis) 
 Severe knee osteoarthritis according to 
the KL classification (grade 4) 
 Other known major musculoskeletal 
impairments in the lower extremities or 
the back or prostheses in any joint of 
the lower extremities 
 Known serious coronary heart disease 
or cancer 
 Body mass index > 35 
 Schedule for surgery in any joint 
 Known mental or psychological 
diseases 
 Known drug abuse 
 Persons who already perform sports 
related moderate physical activity more 
than two times a week 
 Contraindications for MRI 
 Not speaking Norwegian language 
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Only patients randomized to an intervention group in the ongoing randomized 
controlled trial (Oiestad et al., 2013) were included in this study. Subjects included from 
August 1
st
, 2014 until December 31
st
 in the ongoing randomized controlled trial were 
asked to participate. This study planned to recruit 20 patients. The idea was to get 10 
patients from each intervention group (cycling and strength exercises). Unfortunately 
the recruitment process was slower than expected. Since this was not an effect study, no 
power calculation was made as basis for the number of patients. 
From August 2014, a total number of 22 patients in the randomized controlled trail 
(Oiestad et al., 2013) were tested for eligibility. 14 patients met the criteria for inclusion 
in this study, and all but one subject accepted participation. One subject (subject 6) 
withdrew from participation after being recruited due to difficulty understanding the 
questions in the questionnaires. Due to cortisone use, one subject (subject 12) was put 
on hold in the randomized controlled trail. Hence this subject was also excluded from 
this study.  
 
 
 
 
 
 
 
 
 
Figure 4: Flowchart showing the recruitment process in this study. 
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Due to slow inclusion in the main study (Oiestad et al., 2013) the authors decided to 
expand the inclusion criteria for age. From October 10
th
 2014, the inclusion criteria for 
age were set to 40-70 years. Hence, the inclusion criteria for this study also changed 
accordingly. 
4.3 Data collection 
Subjects already randomized to an intervention group in the ongoing study (Oiestad et 
al., 2013) were contacted either by telephone or face to face when they went through 
baseline assessments in the ongoing study. They were asked to participate in this study, 
which implied to answer additional questionnaires either by telephone interview or by 
email. Subjects who agreed to participate in this study were asked to answer the same 
additional questionnaire over a period of 16 weeks. Patients answering additional 
questionnaires by telephone interview did not have a copy of the additional 
questionnaires in front of them. The additional questionnaires were answered daily for 
seven days after baseline assessment in the ongoing study. During the intervention 
period in the ongoing study the additional questionnaires were answered weekly. When 
the intervention was completed in the ongoing study, patients again answered the 
additional questionnaires daily for seven days. Ten patients answered the additional 
questionnaires through telephone interview, while one patient answered by email. 
 
 
 
             
 
Figure 5: Flowchart comparing the assessment process in the randomized controlled trial (Oiestad et al., 
2013) and this study.  
All the eleven included subjects completed assessments in both the randomized controlled trial and this 
study.   
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4.4 Assessments 
In this study the assessments were the pain part of the KOOS and three questions on the 
NRS for pain. Background information (see table 4) and baseline KOOS scores for the 
other subscales (function, ADL, Sport/rec, QOL. See table 5) for the included subjects 
were obtained from the randomized controlled trial (Oiestad et al., 2013). The KOOS is 
self-administered and contains five outcomes, including pain (Roos et al., 1998). It was 
constructed on the basis of a literature review, an expert panel, and a pilot study. The 
KOOS was developed as an extension of WOMAC (Roos & Lohmander, 2003). 
Questions from WOMAC were included to ensure content validity for the older 
population with osteoarthritis. The pain section of the KOOS measure pain intensity 
related to activities, and includes nine questions about pain in different situations where 
participants are asked to rate their pain on a 5-point scale. The first question include 
response options “never”, “monthly”, “weekly”, “daily” and “always”. The last eight 
questions contain the response options “none”, “mild”, “moderate”, “severe”, and 
“extreme”. Each response option is given a score from 0-4. The mean score is divided 
by four and this score is subtracted from 100 giving a final score (see www.koos.nu for 
details). 100 points indicates no problems and 0 indicates extreme problems. 
Approximately ten minutes are required to complete the full questionnaire and it can be 
administered by mail or in the clinic (Roos et al., 1998). Hence, the KOOS cause 
minimal trouble for patients and researchers and impose minimal bias.  
The KOOS was developed for assessing outcome in subjects with anterior cruciate 
ligament injury, meniscus injury, and cartilage damage or osteoarthritis associated with 
knee injury, and has been proved to be a measure of sufficient reliability, validity, and 
responsiveness for surgery and physical therapy after reconstruction of the anterior 
cruciate ligament (Roos et al., 1998). Minimal clinical importance difference (MCID) 
has not been formally assessed for the KOOS (Roos & Lohmander, 2003). In a study 
conducted by Ehrich et al. (2000), ten points was found clinically relevant for 
osteoarthritis patients using the WOMAC pain. Since the KOOS contains the questions 
from the WOMAC, the ten points cutoff for clinically relevant change could also be 
utilized with the KOOS (Roos & Lohmander, 2003). A Swedish version of KOOS has 
been validated, and the clinimetric properties were found to be comparable to the 
American version of the KOOS (Roos, Roos, Ekdahl, & Lohmander, 1998) . The 
Norwegian version of the KOOS was developed on the basis of the Swedish version due 
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to the similarity in language and culture between the two neighbor countries. In a study 
validating the French version of the KOOS, minimal detectable change (MDC) was 
found to be 13,4 points for the pain subscale (Ornetti et al., 2008). 
 
Figure 6: The Norwegian version of KOOS, the pain section that was used in this study. 
The NRS for pain is an 11-point scale where participants rate their pain from 0 
representing “no pain” and 10 representing “worst pain imaginable” (Hawker et al., 
2011). It can be administered verbally or in written form for self-completion (Jensen, 
Karoly, & Braver, 1986). The time needed to complete the questionnaire is less than one 
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minute and NRS is easy to administer and score. Thus the burden for patients and 
researchers is minimal (Hawker et al., 2011). The pain NRS has been proven to be a 
valid and reliable scale to measure pain intensity. A reduction of approximately two 
points has been found to represent a clinically important difference (MCID) (Farrar, 
Young, Jr., LaMoreaux, Werth, & Poole, 2001). However, the pain NRS evaluates only 
one dimension of the pain experienced (Hawker et al., 2011). Hence, it does not capture 
the complexity of the pain experienced or improvements due to symptom fluctuations.  
Participants were asked three questions on the NRS. On a scale from 0 to 10 where 0 
represents “no pain” and 10 represents “worst pain imaginable”: 
1. During the last 24 hours/week, how would you rate your knee pain at the 
highest? 
2. During the last 24 hours/week, how would you rate your knee pain at the 
lowest? 
3. During the last 24 hours/week, how would you rate your knee pain at average? 
When patients were assessed daily they were asked about pain ”during the last 24 
hours”, while when they were assessed weekly they were asked about pain ”during the 
last week”. See appendix 1 for the Norwegian translation. 
4.5 Intervention 
As mentioned, subjects in this study were already included in an ongoing randomized 
controlled trial (Oiestad et al., 2013) and therefore followed intervention as prescribed 
by that study. The intervention programs were either strength exercise or aerobic 
exercise and were guided by physiotherapists at selected physical therapy institutes in 
the Oslo and Akershus area. The programs lasted for 12 weeks with 2-3 training 
sessions per week. In addition, patients went through a pre-phase of 2 weeks to prepare 
for the intervention programs. 
The strength exercise program contained exercises for quadriceps, hamstrings, hip 
abductors, hip extensors, and calf muscles. 8-10 repetitions maximum in 3 series with 
approximately 30 seconds to 1 minute pause between the series were performed. The 
aerobic program contained of 45 minutes ergometer cycling. Included in these 45 
minutes were 10 minutes warm up, 30 minutes on moderate loading (75% of max heart 
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rate), and 5 minutes cool down. To ensure compliance, patients were asked to complete 
diaries which were controlled weekly by physiotherapists.  
4.6 Statistical methods 
Microsoft Excel was used for statistical analyses and for graphical presentation of the 
data. Data from the KOOS pain and the NRS for pain were presented graphically as 
time series for each subject. Data were described both individually and as a group. 
Describing data individually made it possible to evaluate each participants pain 
fluctuation through the baseline phase, intervention phase, and post intervention phase. 
Describing data as a group made it easier to compare to other studies, hence mean, 
minimum, and maximum values were described.  
We chose to present the results from the KOOS pain and the NRS for pain by points. 
Since the KOOS is a 100 points scale and the NRS a 10 points scale, the results could 
easily be converted to percent. For example a 10 points change for the KOOS is also a 
10 percent change for the KOOS. A 2 points change for the NRS for pain is a 20 percent 
change.  
4.7 Ethical perspectives 
The ongoing study (Oiestad et al., 2013) that this study was a part of was already 
approved by the Regional Ethical Committee and the Data Inspectorate in Norway (Ref. 
2012/334). A notification for change was sent to the Regional Ethical Committee 
applying for the additional data collected in this study. This application was approved 
on July 2014 (Appendix 2).  
Participation in the study was voluntary, and all subjects gave their approval of 
participation before inclusion (Appendix 3). The subjects were informed about the aims 
of the study, what participation implied, the right to withdrawal, potential benefit, 
potential inconvenience, and the rules for confidentiality.  
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5. Results 
5.1 Subject characteristics at baseline 
There were a total of eleven subjects that completed this study, eight males and three 
females. Subject 6 and 12 withdrew from the study and are not described in the results 
chapter. The average age among the subjects was 58 (from 45 to 67 years) and the 
average body mass index (BMI) was 28 (from 20 to 37). All subjects had Kellgren and 
Lawrence grade two or three. 
Table 4: Subject characteristics at baseline for each individual, mean, minimum, and maximum values.  
Subject 1 2 3 4 5 7 8 9 10 11 13  μ Min Max 
Age 
Gender 
BMI 
Years with symptoms 
62 
M 
25 
24 
56 
M 
31 
12 
54 
M 
30 
30 
55 
M 
29 
18 
60 
M 
26 
* 
66 
M 
28 
4 
57 
F 
24 
7 
45 
F 
37 
14 
65 
M 
28 
* 
67 
M 
29 
>30 
51 
F 
20 
6 
58 
 
28 
45 
 
20 
67 
 
37 
Subject 6 and 12 withdrew from the study. 
* Subject 5 and 10 answered “many years” when asked about years with symptoms. 
Mean (μ), maximum (max) and minimum (min) scores are summarized on the right- hand side of the 
table. 
BMI = Body mass index 
At baseline, the mean KOOS scores were 58 (from 32 to 79) for the symptoms subscale, 
63 (from 25 to 74) for the function in daily living subscale, 20 (from 0 to 40) for the 
function in sports and recreational activities subscale, and 32 (from 6 to 44) for the 
quality of life subscale. 
Tabel 5: KOOS scores at baseline for each individual, mean, minimum, and maximum values. 
Subject 1 2 3 4 5 7 8 9 10 11 13  μ Min Max 
KOOS symptom 
KOOS ADL 
KOOS Sport/rec 
KOOS QOL 
79 
74 
40 
44 
46 
25 
15 
6 
75 
72 
15 
31 
75 
69 
15 
13 
61 
84 
35 
38 
79 
68 
30 
44 
32 
35 
0 
31 
32 
72 
10 
44 
68 
66 
15 
31 
50 
34 
10 
25 
39 
91 
35 
44 
58 
63 
20 
32 
32 
25 
0 
6 
79 
74 
40 
44 
Subject 6 and 12 withdrew from the study. 
KOOS = Knee injury and Osteoarthritis Outcome Score 
ADL = Activities of daily living 
Sport/rec = Sports and recreational activities 
QOL = Quality of life 
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5.2 Assessments 
The subjects completed on average 25 of the 28 assessments, which resulted in an 
average compliance of 89 percent. The subjects (subjects 1, 3, and 7) with the highest 
compliance completed 100 percent of the assessments while the subject (subject 13) 
with the lowest completed 71 percent of the assessments.  
Table 6: Subject compliance for each individual, mean, minimum, and maximum values. 
Subject 1 2 3 4 5 7 8 9 10 11 13 μ Min Max 
Number of assessments completed 
Compliance (%) 
28 
100 
26 
93 
28 
100 
25 
89 
27 
96  
28 
100 
27 
96 
23 
82 
24 
86 
21 
75 
20 
71 
25 
89 
20 
71 
28 
100 
The table shows the number of assessments completed for each subject. The maximum number of possible 
assessments was 28 (7 at the baseline phase, 14 during the  intervention phase, and 7 at the  post 
intervention phase).  
Subject 6 and 12 withdrew from the study. 
5.3 Summary of results 
The figure at the next page (figure 7) illustrates the KOOS pain scores for the eleven 
subjects during the baseline phase, the intervention phase and the post intervention 
phase. Pain fluctuated differently among the subjects. During the baseline phase, the 
mean fluctuation (difference between the lowest and highest score) in the KOOS pain 
scores was 20 points. During the intervention phase, the mean fluctuation was 28 points. 
During the post intervention phase, the mean fluctuation was 11 points. The subject 
with the highest fluctuation in score during the intervention phase was subject 4 who 
had 72 points fluctuation. The subjects with the lowest fluctuation were subject 9, 10, 
and 13 who had 11 points difference from the lowest to the highest score during the 
intervention phase.  
The results showed that there was in general less pain fluctuations at the post 
intervention phase compared to the intervention phase and the baseline phase. All but 
one subject (subject 8) had higher fluctuations in the KOOS pain scores during the 
intervention phase compared to the post intervention phase. Comparing the post 
intervention phase with the baseline phase, all but two subjects (subject 8 and 11) had 
higher fluctuations in the KOOS pain scores at baseline phase compared to the post 
intervention phase. The trend lines showed that seven subjects had an increasing trend 
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from the baseline phase towards the post intervention phase. Four subjects had a 
decreasing trend. 
 
Figure 7: KOOS Pain Score for each individual and trend lines during the baseline phase, the 
intervention phase, and the post intervention phase. 
The figure describes the KOOS pain scores for all the eleven subjects. For complete description of each 
subject individually see appendix 4. 
KOOS = Knee injury and Osteoarthritis Outcome Score 
Subject 6 and 12 withdrew from the study. 
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In this study, subjects were asked about their minimum, maximum and average pain the 
last 24hour/week at the NRS. The mean fluctuation (difference between the highest and 
lowest score) in the NRS for pain scores was 6 points during the baseline phase, 7 
points during the intervention phase, and 3 points during the post intervention phase. 
The figure at the next page illustrates the scores from the question about pain in average 
during the last 24 hours/week at the NRS. For the minimum and maximum scores, see 
appendix 4. The scores from the question about average pain at NRS showed 
similarities with the KOOS pain scores. Pain fluctuated differently among the subjects 
and the pain fluctuations were less during the post intervention phase compared to the 
intervention phase and the baseline phase. The trend lines showed that eight subjects 
had an improvement in pain (decreasing trend) from the baseline phase towards the post 
intervention phase, while three subjects had a worsening (increasing trend) in pain. 
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Figure 8:  NRS for pain scores for each individual and trend lines during the baseline phase, the 
intervention phase, and the post intervention phase.. 
The figure describes scores from the question about pain in average during the last 24 hours/week at the 
NRS. It is important to notice that 0 represents “no pain” and 10 represents “worst pain imaginable”. 
The scale is opposite of the KOOS scale. For complete description of each subject individually, see 
appendix 4. 
 NRS = Numeric Rating Scale  
Subject 6 and 12 withdrew from the study. 
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5.4 Were baseline and post intervention KOOS pain scores in 
the ongoing randomized controlled trial (Oiestad et al., 
2013) similar to KOOS pain scores in this study? 
The figure below compares the baseline KOOS pain results from the randomized 
controlled trial (Oiestad et al., 2013) with the baseline KOOS pain results from this 
study. Five subjects (subject 4, 7, 8, 10, 13) had similar results, while six subjects 
(subject 1, 2, 3, 5, 9, 11) had results that differed ten points or more.  
 
Figure 9: Comparing baseline  KOOS pain results from the randomized controlled trial (Oiestad et al., 
2013) with this study. 
1,2,3 etc:  Subject number 1, 2, 3 etc 
RCT:  Results from the randomized controlled trial at baseline (one assessment) 
MT:   Average scores at baseline (average of up to seven assessments) in this study 
KOOS = Knee injury and Osteoarthritis Outcome Score 
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The figure below compares the post intervention KOOS pain results from the 
randomized controlled trial (Oiestad et al., 2013) with the post intervention KOOS pain 
results from this study. Seven subjects (subject 1, 2, 3, 5, 7, 9, 10) had similar results, 
while four subjects (subject 4, 8, 11, 13) had results that differed ten points or more. 
 
Figure 10: Comparing the post intervention  KOOS pain results from the randomized controlled trial 
(Oiestad et al., 2013) with this study. 
1,2,3 etc:  Subject number 1, 2, 3 etc 
RCT:  Results from the randomized controlled trial at post intervention (one assessment) 
MT:   Average scores at post intervention (average of up to seven assessments) in this study 
KOOS:   Knee injury and Osteoarthritis Outcome Score 
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6. Discussion 
The main purpose of this study was to evaluate how pain fluctuated over time among 
middle-aged patients with mild to moderate knee osteoarthritis undergoing a 14-week 
exercise intervention. The pain fluctuations (the difference between the highest and 
lowest score) varied substantially among the subjects during the intervention phase. The 
mean pain fluctuation during the intervention phase was 28 points measured with the 
KOOS pain and 7 points measured with the NRS for pain. Our hypothesis that pain 
fluctuations during the intervention phase would be 10 points or more for the KOOS 
pain and 2 points or more for the NRS for pain was confirmed for all subjects.  
Our hypothesis that pain fluctuations would decrease at the post intervention phase 
compared to the baseline phase and the intervention phase was confirmed by the results 
from this study. Compared to the post intervention phase, pain fluctuation measured 
with the KOOS pain was higher during the intervention phase for all subjects, except 
one (subject 8). Measured with the NRS for pain, all subjects had higher pain 
fluctuation during the intervention phase compared to the post intervention phase. 
Comparing the post intervention phase with the baseline phase, all but two subjects 
(subject 8 and 11) had higher pain fluctuations at the baseline phase compared to the 
post intervention phase measured with the KOOS pain. Measured with the NRS for 
pain, all but one subject (subject 13) had higher pain fluctuations at the baseline phase 
compared to the post intervention phase. The trend lines for the KOOS pain showed that 
seven subjects had an increasing trend (pain improved) from baseline phase towards the 
post intervention phase, while four subjects had a decreasing trend (pain worsened). The 
trend lines for the average NRS for pain question showed that eight subjects had an 
improvement in pain (decreasing trend) from the baseline phase towards the post 
intervention phase, while three subjects had a worsening in pain (increasing trend). 
In the last research question we compared the KOOS pain scores in the randomized 
controlled trial (Oiestad et al., 2013) with the KOOS pain scores in this study. At the 
baseline phase the KOOS pain scores were similar for five subjects (subject 4, 7, 8, 10, 
13), while six subjects (subject 1, 2, 3, 5, 9, 11) had results that differed ten points or 
more. At the post intervention phase seven subjects (subject 1, 2, 3, 5, 7, 9, 10) had 
similar results, while four subjects (subject 4, 8, 11, 13) had results that differed ten 
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points or more. Our hypothesis that the results from our study would differ from the 
results in the randomized controlled trial, were not confirmed for all subjects. 
In the following chapters the research questions and the methods will be discussed.  
6.1 Discussion of results 
6.1.1 How did pain fluctuate during the 14-weeks intervention? 
The mean fluctuation at the KOOS pain during the 14-weeks intervention phase was 28 
points. This is somewhat similar to within-day pain fluctuations found among patients 
with hand, hip, and knee osteoarthritis in a study by Allen et al. (2009). They found pain 
to fluctuate on average about 36 points on a scale from 0-100 tested on one weekday 
and one weekend day. The NRS for pain fluctuated more than the KOOS pain in this 
study. These differences between the NRS and the KOOS will be discussed in chapter 
6.2.3 Outcome measures. On average, the NRS for pain fluctuated 7 points during the 
intervention phase, which is also considerably higher compared to a comparable study 
(Hutchings et al., 2007) where similar pain scales were included. Hutchings et al. (2007) 
found pain to fluctuate 4,3 points over a period of 12 weeks. However, the subjects in 
the study conducted by Hutchings et al. (2007) did not undergo an intervention which 
might explain some of the differences in the results from our study. 
Pain fluctuation varied substantially among the eleven subjects. Three subjects in the 
upper end of the scale had pain fluctuations during the intervention phase of accordingly 
72, 55, and 47 points for the KOOS pain. Their pain fluctuations for the NRS for pain 
were 10, 9 and 8. In the lower end of the scale three subjects had 11 points fluctuation 
for the KOOS pain during the intervention phase. For the NRS for pain the scores were 
6, 4, and 4.  
Based on the literature (Roos & Lohmander, 2003) that ten points change is a clinically 
relevant change (MCID) for the KOOS pain, we hypothesized that the subjects in our 
study would achieve this during the intervention phase. This hypothesis was confirmed, 
and all subjects had a clinical relevant change (MCID) according to this literature. 
However, according to another study (Ornetti et al., 2008) minimal detectable change 
(MDC) was found to be 13,4 points for the KOOS pain subscale. According to this 
cutoff, the results from the three subjects with the lowest pain fluctuations during the 
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intervention cannot be reliably distinguished from random error in the measurement 
(Lassere, van der Heijde, Johnson, Boers, & Edmonds, 2001). If we had used the cutoff 
of 13,4 points, the hypothesis would not have been confirmed for these three subjects.  
As mentioned Farrar et al. (2001) found a reduction of approximately two points on the 
NRS to be clinically relevant (MCID) when assessing chronic pain intensity. According 
to this literature all our subjects had clinically meaningful changes on the NRS for pain 
during the intervention phase.   
Why do pain fluctuations occur? 
The literature describes pain fluctuations in patients with osteoarthritis, however why 
these pain fluctuations occur lack knowledge (Allen et al., 2009). In a study conducted 
by Focht et al. (2002), pain fluctuations were found to gradually increase throughout the 
day and reach their peak between 3 and 4 pm among older overweight or obese adults 
with knee osteoarthritis. This happened on a day with no exercise. These results suggest 
that osteoarthritis pain follow a natural or biological rhythm with peak pain fluctuations 
in the second half of the day. Bellamy et al. (2002) found similar results in their study 
investigating patients with hand osteoarthritis. They found pain fluctuations to change 
systematically throughout the day, suggesting that pain fluctuations were predictable. 
These subjects did not exercise either. However, this does not explain the big variations 
in pain fluctuations among the subjects found in this study. 
Collins et al. (2014) also found pain to fluctuate over time in patients with knee 
osteoarthritis. However, the authors found pain to be relatively stable over the course of 
the six years follow up time. Their study found pain fluctuations to be relatively stable 
across the group of osteoarthritis patients, which is somewhat contrary to the results 
from this study. More in accordance with our results are the results from the study 
conducted by Leffrondre et al. (2004). They identified four pain fluctuation patterns 
among 835 subjects with osteoarthritis in the hip or the knee: (1) regularly increasing, 
(2) regularly decreasing, (3) stable, and (4) unstable with fluctuations. Similarly to our 
results, they found some patients to have high pain fluctuations while others had low. 
WOMAC was utilized as the measurement method in both studies (Collins, Katz, 
Dervan, & Losina, 2014; Leffondre et al., 2004), but the patients in the study conducted 
by Leffrondre et al. (2004) had more severe baseline symptoms compared to the patients 
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in the study conducted by Collins et al. (2014). Hence, comparing the results between 
these two studies must be done with caution. 
The osteoarthritis population is heterogeneous, characterized by variable clinical 
features, biochemical and genetic characteristics, and responses to treatment (Driban, 
Sitler, Barbe, & Balasubramanian, 2010). It has been proposed that the heterogeneous 
osteoarthritis population could be divided into different subgroups or phenotypes 
(Felson, 2010). Hence, identifying different phenotypes in osteoarthritis patients may be 
of high importance to treatment and preventing development of the disease. Knoop et al. 
(2011) used clinically patient characteristics to identify phenotypes of knee 
osteoarthritis. The characteristics included radiographic osteoarthritis, muscle strength, 
body mass index and depression. On the basis of these characterizations Knoop et al. 
(2011) identified five phenotypes of knee osteoarthritis patients: ” minimal joint disease 
phenotype”, “strong muscle phenotype”, “nonobese and weak muscle phenotype”, 
“obese and weak muscle phenotype”, and “depressive phenotype”. They found the 
phenotypes “depressive phenotype” and “obese and weak muscle phenotype” to have 
higher pain levels and more severe activity limitations compared to the other three 
phenotypes. Unfortunately, we did not have enough data to determine which phenotype 
each subject belonged to. The phenotype could potentially have explained some of the 
variations in pain fluctuation among the subjects. Subject 9 could potentially have 
belonged to the phenotype “obese and weak muscle phenotype” since she had a BMI of 
37. However, without data about her strength this must be considered with caution. Her 
pain fluctuation was among the lowest though, with 11 points fluctuation in the KOOS 
pain during the intervention period.   
The etiology of pain fluctuations is not well understood (Zhang et al., 2011). Foss et al. 
(2006) suggested that pain fluctuations reflect the interaction between peripheral and 
central processes and the coping mechanisms that patients develop to deal best with the 
condition. Another feature associated to the  pain fluctuations experienced in 
osteoarthritis are inflammation (Bonnet & Walsh, 2005). Both acute inflammation and 
chronic inflammation could contribute, and the symptoms differ between these two. 
Acute inflammation usually has a sudden onset, becoming apparent over minutes or 
hours, while chronic inflammation develops over a longer period of time and may 
persist for days, weeks, or even months.  Zhang et al. (2011) examined the relationship 
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of changes in bone marrow lesions, effusion, and synovitis to fluctuation of knee pain 
among patients in the Multicenter Osteoarthritis study. They found changes in bone 
marrow lesions and synovitis to be associated with fluctuations in knee pain among the 
patients. Bone marrow lesions had the best predictive ability. These results might 
explain some of the acute pain incidents experienced by osteoarthritis patients. 
Pain fluctuations has also been linked to fluctuation in psychological factors, however 
whether the pain influences the mood or vice versa is difficult to distinguish (Wise et 
al., 2010). Even though psychological factors can certainly contribute to a heightened 
pain experience, it is also a possibility that pain itself can contribute to poor mood 
(Neogi, 2013). A study conducted by Evers et al. (2014) found worrying and stress 
vulnerability to be linked to increased disease activity and symptoms in rheumatoid 
arthritis patients. Even though rheumatoid arthritis patients are different from 
osteoarthritis patients, some of the same mechanisms might be present in osteoarthritis 
patients. 
6.1.2 Were pain fluctuations at baseline, during the 14-week intervention 
and at post intervention different from each other? 
Starting with a new exercise program could potentially influence pain fluctuations in 
osteoarthritis patients. Osteoarthritis pain is typically exacerbated by activity and 
relieved by rest (Hunter et al., 2009), hence more fluctuations during the intervention 
phase was expected. This was expected especially in the beginning of the intervention 
phase when the intervention was introduced. Exercise may for some people lead to an 
increase in pain afterwards but the increase in pain are usually gone the day after 
exercise (Focht, Ewing, Gauvin, & Rejeski, 2002). A study of land-based exercise for 
patients with knee osteoarthritis indicated an increase in knee oedema following 
exercise (Rogind et al., 1998). The literature are clear regarding the positive effects of 
exercise for osteoarthritis of the knee though, (Fransen et al., 2015), therefore we 
expected pain fluctuations to decrease over time which it did. Pain fluctuations were 
lower at the post intervention phase compared to the baseline phase and the intervention 
phase.   
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Pain intensity 
Interestingly, pain intensity measured with the KOOS pain was not clearly improving 
post intervention compared to baseline. Six subjects (subject 3 (76 vs 69), 4 (60 vs 56), 
5 (50 vs 37), 8 (43 vs 41), 9 (65 vs 64), and 13(73 vs 71)) had better average KOOS 
pain scores at the baseline phase compared to the post intervention phase (see appendix 
5). Thus, only five subjects had better KOOS pain scores at post intervention phase than 
at the baseline phase. If we look at the trend lines (see figure 7 and appendix 4) though, 
the trend is increasing for seven subjects while decreasing for four subjects. Meaning 
that according to the trend lines pain was improving for seven subjects and worsening 
for four subjects. The results were different if we look at the average NRS for pain 
scores, with three subjects (subject 5, 9, 13) having worse post intervention scores 
compared to baseline scores, while eight had better. The trend lines gave the same 
results with eight subjects improving in pain from the baseline phase towards the post 
intervention phase (decreasing trend), while three subjects were worsening in pain 
(increasing trend) (see figure 8).  
The KOOS pain scores are different from what we could expect based on the literature 
documenting the positive effects of exercise for osteoarthritis of the knee (Fransen et al., 
2015). Even though six subjects had worse average KOOS pain scores at post 
intervention compared to baseline, five of these subjects had differences of less than 
eight points. These small variations could be due to measurement errors and not 
necessarily due to clinical relevant changes. Nevertheless, one would expect the KOOS 
pain post intervention scores to be better considering the literature documenting the 
positive effects of exercise. The results from NRS for pain are in better accordance with 
the literature with most subjects having better post intervention scores compared to 
baseline scores. The numbers of patients are too low to draw any statistical conclusions. 
Therefore, these considerations must be interpreted with caution.  
6.1.3 Were baseline and post intervention KOOS pain scores different 
from the KOOS pain scores these same individuals reported in the 
randomized controlled trial (Oiestad et al., 2013)? 
Due to the growing literature documenting pain fluctuations in patients with 
osteoarthritis (Allen et al., 2009; Hutchings et al., 2007; Bellamy et al., 2002) we 
expected dissimilarity in the results between the randomized controlled trial (Oiestad et 
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al., 2013) and this study. When only having one assessment at baseline and one post 
intervention, the results might be different compared to one assessment daily for one 
week during the baseline phase and the post intervention phase. However, the results 
did not confirm our hypothesis for all the subjects. The results between the two studies 
were more similar than we expected. 
At baseline and post intervention, subjects in the randomized controlled trial (Oiestad et 
al., 2013) were asked about the amount of pain during the last week while subjects in 
this study were asked about the amount of pain the last 24 hours. We expected to see 
more fluctuations in pain in this study since we asked about pain in a shorter timeframe. 
However, the results were similar (less than ten points difference for the KOOS pain) 
for five subjects at the baseline phase and seven subjects at the intervention phase.  
Figure 9 and 10 describes average results at the baseline phase and the post intervention 
phase in this study compared to the one assessment at the baseline and the one 
assessment the post intervention in the randomized controlled trial. Allen et al. (2009) 
suggests that due to pain fluctuations, the day of the week which pain is assessed may 
affect the results. For example, assessing pain on the weekday when pain intensity is 
high may not be representative for the patients pain. Hence, which day you choose to 
assess pain may affect the results. Somewhat contrary, the results from this study might 
indicate that asking about the amount of pain the last week might give a relatively 
representative view of the patients pain intensity even though pain is fluctuating during 
that week.  
6.2 Discussion of methods 
6.2.1 Subjects 
In this study, the mean BMI and age among osteoarthritis patients were similar to the 
data from international studies (Knoop et al., 2011). However, two subjects (9 and 13) 
were different with a BMI of respectively 37 and 20. This study included more than 
twice as many males than females. Considering osteoarthritis is more common among 
females than among males (Chaganti & Lane, 2011), the gender distribution was 
different than what was expected. The included subjects in this study had similar KOOS 
(all five subscales) scores at baseline compared to a newly published study of knee 
osteoarthritis patients (Henriksen et al., 2015). Compared to the subjects in another 
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study of knee osteoarthritis patients (Lund et al., 2008), our subjects had better scores 
for the KOOS subscales pain, symptom and activities of daily living. However, the 
subjects in our study had worse scores for sports and recreational activities and quality 
of life. This might indicate that the subjects in our study had higher expectations to what 
functional level they considered as good.  
Years with symptoms varied considerably among the subjects; between four years 
(subject7) and more than 30 years (subject 11). In a study conducted by Hawker et al. 
(2008), patients described their pain as worsening over time, and being more related to 
activity in the early phase while being more constant in later phases of osteoarthritis. 
Based on this literature, pain fluctuation should be different between these two subjects 
in our study. However, this was not the case. The results were similar for subject 7 and 
11 in which subject 7 fluctuated 20 points for the KOOS pain during the intervention 
phase while subject 11 fluctuated 25 points.  
In summary, subjects in this study were representative for the osteoarthritis population 
according to age and BMI. The duration of symptoms varied between the subjects, from 
four years to more than 30 years. The gender distribution was not representative for the 
osteoarthritis population, with more than twice as many males than females. All 
subjects had Kellgren and Lawrence grade two or three. 
6.2.2 Study design 
Since the overall purpose of this study was to evaluate pain fluctuations among patients 
with knee osteoarthritis undergoing an exercise intervention, a single subject design was 
found appropriate with repeated measurements. To be able to evaluate patients pain 
fluctuations we needed to collect information about each individual patient while they 
underwent the exercise intervention. The single subject design permit collection of data 
during an intervention period while the treatment is being delivered (Ottenbacher & 
York, 1984). Moreover, we needed repeated measurements at the baseline phase, the 
intervention phase, and the post intervention phase to be able to evaluate the fluctuating 
nature of the patients pain. Typically group designs only measures participants a few 
times within the study, making the researcher unable to determine the typical pattern of 
fluctuation (Carter et al., 2011). Group designs often measure patients only one time at 
baseline and one time post intervention. The results then may be due to a natural 
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fluctuation and not necessarily a real change. Single subject designs are characterized 
by extended periods of measurements making it possible to determine the pattern of 
fluctuation. The lack of a control group was a threat to the internal validity, but the 
repeated measurements at baseline allowed us to discount most of the threats to the 
internal validity (Engel & Schutt, 2005).  
AB design is the most basic and has been described as the foundation of single subject 
designs, where A is representing baseline and B intervention (Backman et al., 1997). 
Different variations of the AB design exist. An extension of the AB design is the ABA 
design where the intervention is withdrawn in the third phase (Ottenbacher & York, 
1984). This design is also referred to as withdrawal designs (Engel & Schutt, 2005). In 
our study a post intervention period was added in the end, which made this an ABA 
design. The withdrawal of the intervention provides greater confidence in determining 
the effect of the intervention (Ottenbacher & York, 1984). However, we did not control 
if patients stopped doing exercise after the intervention which means they might have 
continued exercising.  
The limited time for this study made it impossible to include a large number of 
participants. Group designs require usually larger sample sizes to detect differences 
between the groups. Single-subject designs may be used when the number of subjects 
are low (Carter et al., 2011). The participants had big variations in pain fluctuations 
which made it interesting to follow them individually instead as a group. Group designs 
are not designed to follow participants individually. A limitation with single subject 
deigns however, are the generalizability of results which may be low (Carter et al., 
2011). Engel & Schutt (2005) asks: “How is evidence about that single individual 
relevant to other clients?” To counter this limitation, single subject designs should be 
replicated across multiple subjects in different clinical settings according to Backman et 
al. (1997). Our results are first and foremost descriptive for the eleven subjects included 
in this study. To be able to say something about osteoarthritis patients in general, more 
and larger studies are needed.   
The aim was to give a descriptive view of pain fluctuations, hence patients were 
followed over a period of time. To be able to give a representative picture of patients 
daily pain fluctuations, at least four days of pain recordings should be obtained 
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according to Jensen & McFarland (1993). In this study we included seven days of pain 
recordings at both baseline and post intervention. It is in accordance with earlier studies 
describing daily pain fluctuations in patients with osteoarthritis, which included 
respectively two days (Allen et al., 2009) and ten days (Bellamy et al., 2002) of pain 
assessments. However, this study included only one pain assessment per day while 
earlier studies included seven (Allen et al., 2009) and six (Bellamy et al., 2002) 
respectively pain assessments per day. According to Engel & Schutt (2005) a general 
rule is that more data points will increase your certainty about the pattern. Hence, the 
results of this study might have been more accurate for patients pain fluctuations with 
more assessments per day. Due to the amount of resources needed and the scope of this 
study, it was decided to only make one pain assessment daily.  
It was attempted to do the daily pain assessments at the same time of the day for the 
individual patient. However, this was found difficult. Patients did not always answer the 
phone immediately, making it difficult to keep a structured timetable. The result was 
different time intervals between the daily pain assessments, which possibly influenced 
the results since current pain levels may affect pain recall (Jensen, Mardekian, 
Lakshminarayanan, & Boye, 2008). This could have been arranged before the telephone 
interview started by creating a schedule for when the patients could be contacted. 
During the intervention period in the randomized controlled trial (Oiestad et al., 2013) 
we assessed pain fluctuation once a week. The Longitudinal Examination of Arthritis 
Pain Study (Hutchings et al., 2007) has earlier described weekly pain fluctuations 
among hip or knee osteoarthritis patients by assessing pain levels once a week. 
According to the Longitudinal Examination of Arthritis Pain Study (Hutchings et al., 
2007) they were the first study to describe longitudinal relationships between weekly 
changes in pain levels and other health outcomes in adults with osteoarthritis.  
Patients could choose to answer questionnaires either by telephone or by email. Only 
one patient chose to reply by email. Patients who chose to answer by telephone did not 
have a copy of the questionnaires in front of them. Hence, they could not forward fill 
their answers. However, it is possible they remembered their last answer due to the 
short timeframe between the assessments. The subject who replied by email received a 
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new questionnaire for every new assessment. The questionnaire was dated to ensure that 
a copy of the last questionnaire was not forwarded.  
6.2.3 Outcome measures 
Knee Injury and Osteoarthritis Outcome Score 
The KOOS has undergone a substantial amount of psychometric testing, and has been 
established as a reliable and valid measure for patients with knee osteoarthritis (Collins, 
Misra, Felson, Crossley, & Roos, 2011). The use of individual scores for each subscale, 
rather than an aggregate score, makes it easy to get an overview on different dimensions 
which are important since osteoarthritis patients are a heterogenic population. However, 
it has not been validated for use during telephone interviews (Collins et al., 2011). 
Therefore, caution is needed when interpreting results from this study.  
Another limitation by using the KOOS is that patients are reporting answers by 
memory, which creates a risk for recall bias. When people are recalling from memory, it 
creates a risk for systematic errors (Laake, Olsen, & Benestad, 2008). The short time 
that patients had to recall (one week or 24 hour) makes the risk of recall bias less.   
Numeric Rating Scale for Pain 
The NRS for pain has been observed as a reliable and valid tool for detecting changes in 
pain intensity in rheumatic disease and chronic pain conditions (Hawker et al., 2011). 
This also includes when the NRS for pain is utilized during telephone interviews. Like 
all self reported answers by memory, the risk of recall bias is also present for the NRS 
for pain. 
Comparing KOOS and NRS 
As mentioned, the results for the KOOS pain and the NRS for pain demonstrated some 
differences. One basic difference between these two assessments tools is the way the 
questions are asked. The KOOS pain is focusing on pain related to an activity, while the 
NRS for pain in this study was focusing on pain in general. Asking a person how much 
pain they experienced related to an activity is different from asking a person about how 
much pain they experienced in general. Hence, the results from these two measurements 
might be different. 
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Another difference between the KOOS pain and the NRS for pain in our study was the 
timeframe of the questions. When utilizing the KOOS pain, subjects were asked about 
the amount of pain either the last week or the last 24 hours. This could be interpreted as 
the amount of pain on average during the last week or the last 24 hours. When utilizing 
the NRS for pain, subjects were asked three questions. They were asked about the 
minimum, maximum and average pain during the last week or 24 hours. Asking about 
maximum and minimum pain could potentially give more fluctuations in answers 
compared to asking about the amount of pain. Therefore, the question about average 
pain for NRS might be more similar to the KOOS pain questions. Hence, this might be 
the reason why the results from the average NRS for pain (when not including 
maximum and minimum NRS) were more similar to the results from the KOOS pain.  
The way these to measurements are scored are also different. At the KOOS a higher 
score indicate lower pain intensity, while at the NRS for pain a higher score indicate 
higher pain intensity. This is important to remember when interpreting the graphs 
(figure 7, 8, and appendix 4) with the results from the KOOS pain and the NRS for pain. 
6.2.4 How the data was presented 
Visual analysis of data is the traditional method used in single subject design research 
(Wolery & Harris, 1982). Since single-subject designs emphasize the examination of a 
subjects individual fluctuations of performance, and because of the rules for using 
statistical analyses of subject data, visual analysis is the favored method of evaluating 
results in single subject designs (Carter et al., 2011). Hence, the results from our study 
were also presented in a visual manner. By creating time series for each subject, trends, 
levels, and variability for each subject’s results were visualized.  Level is the difference 
between two assessments. Trend is the direction of change of the results, and could be 
increasing, decreasing, or cyclical. Variability means how different or divergent the 
scores are within a baseline or intervention phase (Engel & Schutt, 2005). By visually 
analyzing the lines going through the data points you could interpret the direction of the 
trend. A trend line was added to the graphs making it easier to visualize the trends of the 
results (see figure 7, 8, and appendix 4).    
There is a possibility that results presented visually may be interpreted by the reader 
inconsistently (Ottenbacher & York, 1984). To meet this problem results should be 
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analyzed both statistically and visually according to Ottenbacher & York (1984). 
Therefore, results from this study were also presented by numbers in addition to visual 
presentations (see appendix 5 and 6). 
6.3 Clinical implications 
This single subject design study has shown that there are large variations in pain 
fluctuations among patients with knee osteoarthritis. Even though patients may be 
similar in BMI, age, and Kellgren and Lawrence grade of osteoarthritis, their pain 
fluctuations might be very diverse. Some patients had high pain fluctuations, while 
other patients had more stable pain fluctuations. It is important to remember that 
fluctuations in pain are normal when treating and evaluating osteoarthritis patients, both 
in the clinic and in research. It is also important to inform the patients about the 
fluctuating nature of osteoarthritis pain. Assessing individuals patterns of pain 
fluctuations can help with recommendations for timing of treatment (Allen et al., 2009).  
6.4 Future research 
If we could predict which patients who would have high pain fluctuations we could 
easier adjust treatment to the individual needs. Studies looking at what characterizes the 
patients with high pain fluctuations could potentially answer this question. For example 
a certain phenotype of osteoarthritis patients may have high pain fluctuations.   
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7. Conclusion 
This study showed that overall, according to a cutoff of ten points for the KOOS pain 
and two points for the NRS for pain patients with knee osteoarthritis reported clinically 
meaningful (CMID) pain fluctuations during a 14-week intervention period. Pain 
fluctuations varied substantially among the eleven subjects. Some patients had high pain 
fluctuations while others had more stable pain fluctuations. In general, pain fluctuated 
less at the post intervention compared to the baseline and during the intervention. The 
results from this study add to the literature documenting pain fluctuations in patients 
with knee osteoarthritis. 
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Appendix 5: Results for KOOS pain and NRS presented by numbers 
The table summarizes maximum, minimum, and average scores for KOOS pain and 
NRS for pain at baseline, intervention, and post intervention. 
Subject 1 2 3 4 5 7 8 9 10 11 13 
KOOS pain maximum baseline 
KOOS pain minimum baseline 
KOOS pain average baseline 
KOOS pain maximum intervention 
KOOS pain minimum intervention 
KOOS pain average intervention 
KOOS pain maximum post intervention 
KOOS pain minimum post intervention 
KOOS pain average post intervention 
NRS maximum baseline 
NRS minimum baseline 
NRS average baseline 
NRS maximum intervention 
NRS minimum intervention 
NRS average intervention 
NRS maximum post intervention 
NRS minimum post intervention 
NRS average post intervention 
81 
69 
78 
94 
78 
89 
94 
92 
93 
3 
0 
1,3 
4 
0 
0,9 
2 
0 
0,1 
69 
22 
44 
69 
22 
44 
58 
42 
47 
8 
0 
4,1 
10 
2 
4,8 
5 
3 
3,3 
83 
69 
76 
72 
17 
58 
75 
67 
69 
5 
0 
2,1 
9 
0 
3,4 
4 
0 
2,1 
75 
31 
60 
75 
3 
62 
67 
50 
56 
9 
0 
3,3 
10 
0 
2,6 
6 
0 
3 
56 
42 
50 
39 
19 
29 
42 
31 
37 
7 
2 
5,1 
10 
4 
6,6 
8 
4 
5,8 
86 
69 
77 
89 
69 
81 
92 
83 
88 
7 
0 
1,6 
8 
0 
1,6 
3 
0 
1 
53 
39 
43 
44 
25 
33 
53 
33 
41 
8 
0 
5,3 
9 
0 
6,1 
7 
0 
5,2 
 
69 
61 
65 
61 
50 
56 
67 
58 
64 
5 
0 
3,7 
6 
2 
4,1 
4 
4 
4 
83 
58 
74 
86 
75 
81 
86 
81 
83 
5 
0 
2,9 
6 
0 
2,5 
5 
0 
2,5 
72 
61 
67 
94 
69 
82 
94 
81 
85 
6 
0 
2,4 
5 
0 
1,3 
2 
0 
0,5 
78 
64 
73 
78 
67 
70 
75 
67 
71 
3 
0 
1,8 
4 
0 
2,2 
3 
0 
2 
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Appendix 6: Fluctuations in KOOS pain and NRS for pain presented by numbers. 
The table summarizes the difference between the highest and lowest score (fluctuation) 
for each subject during baseline, intervention, and post intervention. 
Subject 1 2 3 4 5 7 8 9 10 11 13   μ Min Max 
KOOS pain fluctuation baseline 
NRS fluctuation baseline 
KOOS pain fluctuation intervention 
NRS fluctuation intervention 
KOOS pain fluctuation post intervention 
NRS fluctuation post intervention 
12 
3 
16 
4 
2 
2 
47 
8 
47 
8 
16 
2 
14 
5 
55 
9 
8 
4 
44 
9 
72 
10 
17 
6 
14 
5 
20 
6 
11 
4 
17 
7 
20 
8 
9 
3 
14 
8 
19 
9 
20 
3 
8 
5 
11 
4 
9 
0 
25 
6 
11 
6 
5 
5 
11 
5 
25 
5 
13 
2 
14 
3 
11 
4 
8 
3 
20 
6 
28 
7 
11 
3 
8 
3 
11 
4 
2 
0 
44 
9 
72 
10 
20 
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